Latest analysis data cutoff: 12 August 2026. Page refreshed: 19 August 2026.
Synthesizing evidence¶
State of the evidence¶
As of mid-August, there have been over 4,000 DRC cases, 20 Uganda cases, and one France case [1]. The evidence base is broad but still emerging, comprising peer-reviewed risk assessments or reviews, preprints, and one dashboard, with analyses dated from 20 May to 12 August 2026. The evidence base continues to grow, with later analyses reflecting wider DRC spread, Uganda’s controlled spread, and airport reopening.[2][3]
How the estimates compare¶
The studies converge on highlighting significant spillover risks within the region, with various analyses placing Uganda, South Sudan, Rwanda, Kenya, Tanzania, and Zambia among the highest-risk African destinations under multiple scenarios.[4][5] The main divergence between analyses is methodological, with air traffic-focused models elevating the ranking of international hubs such as Belgium, France, South Africa, Kenya, and the UAE, whereas land-plus-air models elevate contiguous and near-contiguous African countries.[6][7] Inside DRC, Okingo et al. show why importation and amplification risk should not be conflated. Areas near the outbreak epicenter rank high for introduction, while high potential for sustained transmission mainly appears in more distant urban centers, including Kinshasa.[8][9]
Key uncertainties and assumptions¶
A shared challenge is the dependence on mobility data and assumptions of homogeneity in travel behavior[10]. Geographic spread estimates hinge on surveillance data quality, which varies[11][12]. The validity of historical patterns to project future outbreaks under diverse settings adds uncertainty[13].
What would reduce uncertainty¶
First, verified, onset-dated line lists with health-zone location, travel history, contact status, onset-to-isolation delay and outcome would reduce uncertainty by allowing analyses to distinguish true transmission trends from changing surveillance.[14][15] Second, would be dynamic mobility data, particularly targeting high-risk corridors in Africa,[16] plus reliable air traffic data, since rankings are highly sensitive to cross-border and hub connectivity.[17][18] Organizations such as Flowminder aim to fill this gap by providing more real-time data on mobility trends. Third, comparable assessments of health emergency preparedness across potential destinations, covering laboratory access, infection prevention and control, isolation, contact tracing, and referral pathways, would help, since sustained-transmission risk depends on a destination’s containment capacity, not importation alone.[19][20]
Open questions¶
Several analyses call for regular updating rather than one-off estimates.[14][18][21] They also leave unresolved whether assumptions around early or mild symptomatic travel, humanitarian or charter flights, and changing land mobility would materially shift rankings, and Walekhwa et al. additionally call for refined epidemiological parameter estimates for BDBV, particularly infectious period and serial interval.[22][23][24]
What this means for the response¶
The evidence suggests emphasizing preparedness in Uganda and South Sudan due to their high importation risks and varied readiness profiles[25][26]. Ensuring capacity to manage and isolate cases upon detection is necessary[27], alongside enhanced cross-border surveillance and testing capacities[28]. The analyses establish a strong need for ongoing vigilance and rapid response capabilities in these and surrounding countries, allowing for timely adjustments in strategy as new data emerges. For DRC, the evidence suggests maintaining attention beyond the eastern hotspots, including Kinshasa and other urban health zones where amplification potential is high despite distance from the hotspots.[9] For intercontinental destinations, the evidence suggests focused preparedness, including travel-history recording, diagnostics, isolation capacity, and occupational-exposure protocols, rather than reliance on border screening, because historical exportation outside Africa is rare and mostly occupational or response-linked.[29][30][31][32][33]
Individual analyses¶
Verheyden and Mudogo (12 Aug 2026) Incidence-weighted force of infection for predicting first reported health-zone cases during the 2026 Bundibugyo virus disease outbreak: a rolling-origin evaluation¶
Overview¶
This analysis estimates which currently unaffected health zones in four DRC provinces are at highest near-term risk of reporting their first confirmed Bundibugyo virus case, in order to support prepositioning of response capacity. Four connectivity specifications — no connectivity term, road-distance, a gravity score, and an incidence-weighted force-of-infection (FOI) term — were fitted within an identical Bayesian hierarchical hazard architecture across 106 health zones in four affected provinces.[34] The FOI specification achieved the highest top-10 hit rate (42.6%), though on a global discrimination metric (AUC-PR), a model with no connectivity term performed as well as or better than any connectivity specification (0.437 vs. 0.409 for FOI).[35]
Estimate¶
This analysis does not estimate total outbreak size or case counts; its output is a ranked list of at-risk health zones by their estimated daily hazard of first reporting a confirmed case. The top-ranked zone, Rethy (Ituri), had a posterior median daily hazard of 0.095 (95% CrI [0.018, 0.295]), corresponding to roughly a 75% chance of reporting a first case within 14 days if current conditions persisted; the 20th-ranked zone’s daily hazard corresponds to roughly 4% over the same window.[36] On the pre-specified primary metric (top-10 hit rate), FOI was highest (42.6%), followed by OSRM-distance and gravity (both 32.8%), then baseline (29.5%).[37] On AUC-PR (a secondary metric), the baseline model with no connectivity term performed as well as or better than every connectivity specification (baseline 0.437 vs. FOI 0.409, gravity 0.399, OSRM-distance 0.239), and FOI’s advantage over baseline on this metric was not distinguishable from zero (−0.027, 95% CI [−0.274, 0.200]).[38] Across the kernel sensitivity grid of 8 alternative combinations, the resulting zone ranking correlated with the primary specification’s ranking at Spearman ρ = 0.90–0.99, with top-10 overlap of 9 or 10 out of 10 zones in every combination tested.[39]
Methods¶
Discrete-time hazard model with incidence-weighted force-of-infection (FOI): A discrete-time hazard model represents spatial connectivity through the observed incidence in every currently affected zone, propagated to at-risk zones through a road-network distance-decay kernel, referred to as an incidence-weighted spatial force-of-infection (FOI) hazard model.[40] Daily case data come from the INRB-UMIE BDBV2026-Data repository; static covariates include WorldPop population estimates, OpenStreetMap/HOT health-facility points, Complex Crisis Vulnerability Index, and province-level ACLED conflict events; road-network travel times come from a national OSRM graph.[41] CDR/mobility data were not used, as DRC is not among the countries for which this is available.[42] The model is applied to the 106 health zones in Ituri, Nord-Kivu, Haut-Uele, and Tshopo provinces. A sensitivity analysis varied the FOI kernel’s decay scale (φ ∈ {30, 60, 120} minutes) and smoothing window (1, 3, 7 days) across a grid of 8 alternative combinations, reporting ranking stability rather than re-selecting a best-performing specification.[43]
Architecture-matched comparison of four connectivity specifications: Four specifications of the connectivity covariate were compared within the identical model architecture: (1) a baseline with no connectivity term (static covariates only), (2) road-distance (log travel time to the nearest already-affected zone), (3) a population-weighted gravity score summed over all affected zones, and (4) the incidence-weighted FOI term as the primary specification.[44] Fitting all four within the identical architecture isolates what each connectivity term contributes beyond the static covariates and beyond each other.[45]
Rolling-origin pseudo-prospective evaluation: Eight weekly origins from 21 May to 9 July 2026 were used, each refit on data available through that origin and scored against zones reporting a first case within the following 14 days; top-10 hit rate — the proportion of true next-invading zones ranked in the model’s top 10 — was pre-specified as the primary metric.[46] Uncertainty quantification used a cluster bootstrap resampling whole origins with replacement (10,000 resamples).[47] Two further robustness checks were applied: leave-one-origin-out and a non-overlapping-origin subset of 4 origins spaced exactly 14 days apart.[48]
Exploratory growth-rate extension for already-affected zones: A secondary exploratory analysis examined near-term case growth for the 47 already-affected zones using a hierarchical negative-binomial growth-rate model, after an initial Poisson specification was found miscalibrated on rolling-origin backtesting.[49] This is not presented as a second validated model of comparable standing, and a combined invasion-plus-growth ranking is not presented as a validated decision tool, as that combined ranking has not itself been backtested.[50]
Assumptions¶
FOI kernel parameters: The FOI term uses a distance-decay kernel K(z,z’) = exp(−d(z,z’)/φ) with φ = 60 minutes as the default decay scale, and a 3-day trailing mean of new confirmed cases through day t−2 as the incidence weight.[51] The decay scale and smoothing window were not tuned against performance; across a grid of 8 alternative combinations (φ ∈ {30, 60, 120} minutes × window ∈ {1, 3, 7} days), the resulting zone ranking correlated with the primary specification at Spearman ρ = 0.90–0.99, with top-10 overlap of 9 or 10 out of 10 zones in every combination, indicating the ranking is stable across plausible kernel choices.[52]
Temporal lag to avoid leakage: Same-day leakage is addressed by using only incidence through day t−2, never day t or t−1, to construct the FOI covariate.[53] An earlier, same-day (non-lagged) specification yielded a FOI coefficient of +0.610 [0.43, 0.79] compared to +0.357 [0.16, 0.55] after applying the lag, indicating same-day leakage had inflated the apparent effect by roughly 40%.[54]
Outcome definition: The outcome modelled is a zone’s first reported confirmed case, not the date of biological introduction of the virus; first confirmation reflects viral introduction, local transmission, detection, testing access, reporting capacity, and retrospective case reclassification jointly, and the model cannot separate these.[55]
Static covariates and structural form: Health-facility density (β = +0.486, [0.245, 0.734]) and population (β = +0.400, [0.087, 0.720]) are associated with hazard at the 95% credible level and are included as structural inputs; socioeconomic deprivation (+0.326, [−0.074, 0.754]) and province-level conflict exposure (+0.156, [−0.640, 0.900]) were not distinguishable from zero.[56] Conflict exposure is measured only at province level across four provinces, alongside a province random effect estimated from the same four groups; this covariate’s estimate is described as exploratory.[57]
Data-vintage leakage and pseudo-prospective evaluation: Data-vintage leakage — whether case counts available for a historical date already reflect corrections made after that date — cannot be ruled out, since only the final, most recently corrected dataset is held rather than dated historical snapshots; the rolling-origin evaluation is therefore described as pseudo-prospective throughout, not a true contemporaneous test.[58]
Province random effect: A non-centred province random effect is included in the linear predictor alongside a piecewise-constant weekly baseline evolving as a random walk and weakly informative priors.[59]
Limitations¶
Pseudo-prospective evaluation and data-vintage leakage: Because historical snapshots of the surveillance dataset at each rolling-origin date were not available, the authors cannot rule out that retrospective data revision is reflected in what the evaluation treats as contemporaneously known information; the rolling-origin evaluation is therefore described as pseudo-prospective throughout, reserving the term prospective for the genuinely pre-registered future verification.[60]
Outcome reflects detection as well as introduction: The outcome modelled is first reported confirmed case, not the unobserved date of viral introduction; these differ to the extent that introduction, local transmission, detection, testing access, and reporting capacity differ across zones, and the model cannot separate these mechanisms. This matters specifically for the health-facility-density covariate, whose positive association with hazard may partly or wholly reflect greater detection capacity in better-served zones rather than, or in addition to, genuinely greater introduction risk.[12]
Absence of mobile-phone mobility data: Existing approaches to spatial spread typically rely on mobile-phone call detail record data, which a systematic review found available in only a small number of African countries, not including DRC; CDR data were therefore not used in this analysis.[61][42]
Statistical uncertainty in the primary comparison: The top-10 hit rate comparison against road-distance reaches only the boundary of conventional significance (CI lower bound 0.000); the authors state they would not describe this as a robust result on its own and rely on convergent evidence across the primary metric, the sensitivity grid, and the leave-one-origin-out and non-overlapping-origin checks collectively.[62]
AUC-PR divergence: On AUC-PR, the baseline model with no connectivity term performed as well as or better than every connectivity specification; the authors report this plainly, noting that a global discrimination metric rewards correctly ranking the bulk of zones that will not invade soon, which static covariates alone appear to do reasonably well, while the connectivity terms’ distinguishable contribution is specifically to sharpening the top of the ranking.[63]
Conflict exposure measured only at province level: Conflict exposure is measured only at province level across four provinces, alongside a province random effect estimated from the same four groups; the authors state this covariate’s estimate should be read as exploratory.[57]
Growth-rate extension not combined with hazard model: The growth-rate extension has not been backtested as a combined ranking with the hazard model, and the authors do not present one for that reason.[64]
Fixed modelling choices not evaluated: Fixed choices not evaluated in this analysis include the OSRM travel-time transformation and the province-level (rather than zone-level) conflict aggregation.[65]
Data sources¶
Primary outbreak data: Daily case data come from the INRB-UMIE BDBV2026-Data repository (Mbulayi et al., 2026).[66] The study period covers 14 May to 26 July 2026, yielding 5,727 zone-day observations and 47 first-case events across the risk set.[67][68]
Auxiliary data: Static covariates include WorldPop population estimates, OpenStreetMap/HOT health-facility points, Complex Crisis Vulnerability Index, and province-level ACLED conflict events.[69] Road-network travel times were derived from a national OSRM graph.[70] CDR/mobility data were not used, as DRC is not among the countries for which such data are available.[42] An independent Flowminder-based mobility analysis (Bangelesa et al., 2026, as summarised in Walekhwa et al., 2026) found the outbreak’s three epicentre zones among the top 5% of DRC health zones nationally on mobility intensity; this was used as external, indirect support for the general connectivity premise, not as a model input.[71]
Epistorm (23 Jul 2026) Ebola Bundibugyo Virus — DRC · Spread Risk Assessment · International Dissemination¶
Overview¶
This analysis is not an outbreak-size estimate but a geographic risk assessment: it estimates where an exported BVD case is most likely to be detected internationally, conditional on at least one export occurring. The method combines air-travel and short-scale commuting flows into a “mobility-only relative importation risk (RR)” using the GLEAM (Global Epidemic and Mobility) framework, evaluated over a two-week horizon, with no transmission model used at this stage; the analysis describes where any exported case is most likely to be detected, conditional on at least one export occurring[72]. The headline finding is that proximity spillover concentrates in western Uganda and Juba, with 99.2% of the city-level relative-risk mass across neighbouring countries sitting in five cities: Kasese (Uganda, 56.3%), Pakuba (Uganda, 25.4%), Arua (Uganda, 12.8%), Juba (South Sudan, 3.1%), and Entebbe (Uganda, 1.5%)[73], and that once Uganda is removed, South Sudan takes 80.1% of the tail (Juba alone 79.6%)[74].
Estimate¶
This analysis does not produce an outbreak-size estimate; it produces a conditional destination-risk ranking. At the neighbouring-country/city level, the mobility model concentrates 99.2% of the non-DRC relative risk mass in a small number of cities on the eastern side of the country: Kasese, Pakuba, Arua, Entebbe (Uganda) and Juba (South Sudan)[75], with Uganda alone accounting for 96.1% of the non-DRC mass[76]. After removing Uganda and renormalising the remaining 117 destinations, the tail is dominated by South Sudan: Juba alone carries 79.6%, and Rumbek adds a further 0.5%, reflecting the strong overland connectivity from north-eastern DRC into South Sudan captured by the mobility model[77]. Regionally, Africa carries 89.4% of the tail (South Sudan alone 80.1%; then Kenya 2.8%, Tanzania 1.1%, Rwanda 0.8%, South Africa 0.8%, Ethiopia 0.7%), the Middle East accounts for 4.9% (UAE 3.2%, Saudi Arabia 0.9%, Qatar 0.3%), Europe for 3.0% (United Kingdom 1.0%, Germany 0.3%, Belgium 0.3%), Asia for 2.0% (India 0.9%, China 0.7%), and the Americas for 0.7%[78]. The authors emphasize that the absolute probability of any single international export remains small[79], and that these are conditional shares, not absolute probabilities (representing the share of international export probability that would land in each destination if an international export were to occur, not the absolute probability that an export will occur[80]).
Methods¶
Mobility-only relative-risk (RR) model (GLEAM framework): The analysis models importation risk by combining global air travel patterns from IATA/OAG passenger-level origin-destination flows with short-scale commuting patterns capturing daily movements between adjacent subpopulations, following the GLEAM (Global Epidemic and Mobility) computational framework[81]. For each candidate destination, the model estimates the probability that an infected individual originating in the affected area travels there, conditional on at least one exported case occurring, producing a relative risk distribution normalized so that values represent the share of importation probability assigned to each location[82]. The method is applied at two geographic scales as two “views” over the same RR distribution: a city-level view across DRC’s neighbouring countries before renormalisation, showing Uganda alone accounts for 96.1% of the non-DRC mass[83], and a second view that removes only Uganda and renormalises the remaining mass over 117 international destinations reachable by air[84]. No sensitivity analyses varying model inputs are reported; the framework itself is stated to be unchanged from prior reports (the framework is unchanged from Reports #1 to #4[85]).
Assumptions¶
Mobility-only, no transmission dynamics: The model treats importation purely as a function of travel mobility; the report uses the mobility framework only, with no transmission-dynamics model applied, and RR values should not be read as forecasts of future case counts at any destination[86].
No border-control interventions: The mobility model does not simulate country-level border-control interventions such as entry screening, restrictions on travellers from the affected area, or air-service suspensions[87][88], so RR values are described as a mobility-only baseline[89][90].
Incubation period constraint: The incubation period of Bundibugyo virus (2-21 days; average ~10 days) constrains the window within which an exported case could reasonably travel while infectious or pre-symptomatic.[91]
Independence and homogeneity of travellers: Case importations are modelled as statistically independent events.[92] The model also does not incorporate sociodemographic attributes of travellers (age, economic status, occupation, or pre-existing medical conditions); travel probability within a catchment area is treated as independent of these attributes and of specific location within the catchment[93], and estimates apply to traffic from the general population[94], excluding repatriation flights, responder evacuations, or other ad-hoc operational movements[95].
Limitations¶
No border-control modelling affects absolute but not conditional risk: The mobility model does not simulate country-level border-control interventions such as entry screening, restrictions on travellers, or air-service suspensions; any such measure would in particular reduce the absolute probability of an international export, while the conditional ranking of where an export would land is less sensitive but still affected.[2]
Informal cross-border movement undercaptured: Mobility data may not fully capture informal cross-border movement, which is substantial within the immediate cross-border region but is not the focus of the international-tail analysis in Sections 4 and 5.[96]
No downstream transmission modelling: The model does not predict downstream transmission chains following an importation event: risk estimates reflect the probability of a single importation and do not account for the probability of sustained local transmission in the receiving location.[97]
Clustered travel undercounts exposure events: Real-world events involving multiple related cases (for example, a family cluster travelling together) are counted as a single importation event; to the extent that such clusters are common, the model will under-count the number of distinct exposure events while correctly counting the number of distinct geographic seedings.[98]
Sociodemographic and operational-travel exclusions: The model does not incorporate sociodemographic attributes of travellers, and the importation risk associated with repatriation flights, responder evacuations, or other ad-hoc operational movements is not part of this analysis.[99][95]
Data sources¶
Primary outbreak data: 23 July 2026 DRC data[100] underlying the refreshed assessment. Auxiliary data: global air travel patterns derived from the International Air Transport Association (IATA) and the Official Airline Guide (OAG), providing passenger-level origin-destination flows between international airports[101], complemented by short-scale commuting patterns capturing daily movements between adjacent subpopulations, representing the local spread of disease through routine human activity within and across health zones[102]. The incubation period parameter is drawn from the historical 2007 outbreak (2-21 days, average ~10 days, from the 2007 outbreak[103]), and pathogen background notes Bundibugyo virus, second Ebola species, first isolated 2007 in Uganda, confirmed CFR ~14% (DRC/UGA combined)[104].
Bouhentala & Kadir (15 Jul 2026) Epidemiological Analysis of the 2026 Bundibugyo Virus Disease Outbreak and Rapid Risk Assessment for North Africa and Europe¶
Overview¶
This analysis assesses the risk of introduction and onward transmission of the 2026 BDBV outbreak into North Africa and Europe, using publicly available aggregate surveillance data synthesized through mid-July 2026. Risk was assessed across four dimensions: introduction likelihood, conditional onward-transmission likelihood, impact, and confidence.[105] Introduction likelihood was assessed as very low to low for North Africa and very low for the general European population, with delayed recognition in routine healthcare identified as the principal scenario for limited secondary transmission.[29]
Estimate¶
This analysis does not produce a quantitative outbreak-size estimate for DRC. It reports observed surveillance counts as descriptive figures rather than model-derived estimates. As of 15 July 2026, the DRC had reported 2,124 laboratory-confirmed cases, 828 deaths among confirmed cases, 390 reported recoveries, and 725 patients hospitalised in isolation, across 46 of 140 health zones in five provinces.[106] The headline epidemiological trend finding is a notification-rate ratio: the aggregate rate was 35.9 per day during 2–29 June (970 notifications over 27 days; exact counting interval 33.7–38.3) and 47.4 per day during 1–15 July (664 over 14 days; 43.9–51.2), yielding a July-to-June notification-rate ratio of 1.32 (counting-model 95% interval 1.20–1.46).[107] For importation risk, the analysis cites an external ECDC estimate rather than producing its own: ECDC estimated approximately one importation per 23,000–24,000 travellers from the principal outbreak region (90% uncertainty interval one per 13,000–54,000), and under a hypothetical scenario of 100 travellers during 11–25 June, estimated a 0.45% probability of at least one importation (90% uncertainty interval 0.20%–0.85%).[108]
Methods¶
Rapid public-health risk assessment using aggregate surveillance data: This was a rapid public-health analysis of publicly available aggregate surveillance data and official risk assessments, drawing on WHO Disease Outbreak News, WHO/IHR statements and technical guidance, ECDC surveillance and modelling reports, WHO regional offices, national ministry-of-health dashboards, and peer-reviewed primary studies for historical BDBV outbreaks, viral persistence, and candidate countermeasures.[109] Airline sources were used only to establish the existence of plausible routes and not to estimate passenger volumes.[110] This approach covers DRC nationally (with provincial detail for Ituri) as the source population, and North Africa and Europe as destination geographies.
Interval-specific notification-rate analysis: Cumulative confirmed DRC counts were indexed by reporting date rather than symptom-onset date, and interval-specific average notification rates were calculated as the change in cumulative confirmed cases divided by the number of days between reports, with exact 95% Poisson counting intervals calculated using the Garwood method.[111] The notification-rate ratio comparing 1–15 July with 2–29 June was calculated on the log scale using SE[log(RR)] = √(1/C₁ + 1/C₀).[112] No reproduction number was estimated because onset-date line-list data were unavailable.[113]
Structured qualitative risk rating: Risk was separated into four dimensions — introduction likelihood, conditional onward-transmission likelihood after an importation, impact if detection was delayed, and confidence in the judgement — with categories treated as comparative reference classes rather than calibrated probabilities; boundary ratings such as ‘very low to low’ were retained when the evidence did not support a more precise classification.[114] The ratings were calibrated against WHO’s 6 June assessment, which classified risk as very high in the DRC, high in Uganda and bordering countries, low in the remainder of the WHO African Region, and low globally.[115]
Assumptions¶
Reporting-date indexing and its limitations: The Poisson counting intervals describe counting variation only and do not incorporate systematic uncertainty from backlogs, under-ascertainment, changing testing, or reporting delays.[116] The observed increase in notification rates cannot be interpreted as a direct measure of biological acceleration, as WHO noted that expanded surveillance, testing, and diagnostic capacity contributed to rising reported counts, and newly reported cases could include backlogs.[117]
Risk ratings as comparative reference classes rather than calibrated probabilities: Risk categories are comparative reference classes rather than calibrated probabilities.[118] Passenger-volume and confidential readiness data were unavailable[119], so country ratings rest on route availability, occupational exposure patterns, and qualitative preparedness indicators rather than quantified traveller volumes.
Transmission requires direct contact: A recognised symptomatic case can usually be contained because transmission requires direct contact with blood or other body fluids, contaminated materials, or the body of a deceased case rather than ordinary casual proximity.[120] This structural assumption underpins the low conditional sustained-transmission rating for North Africa and Europe.
Border screening ineffectiveness during incubation: An incubating traveller can cross a border while asymptomatic because people are not considered infectious before symptom onset and the incubation period can extend to 21 days; temperature screening may detect some symptomatic travellers but cannot exclude infection during incubation.[121]
Itinerary concealment risk: A final departure airport may conceal earlier travel to eastern DRC; triage therefore requires a complete 21-day itinerary and exposure history.[122]
Cumulative doubling time not treated as a transmission signal: Arithmetic cumulative doubling times were treated as descriptive properties of the cumulative curve and not as evidence of changes in transmission.[123]
Limitations¶
Dependence on public aggregate data: The main limitation is dependence on public aggregate data; reporting dates do not represent symptom onset, and the analysis could not estimate time-varying reproduction numbers, serial intervals, onset-to-isolation delays, household secondary-attack rates, health-zone-specific growth, or intervention effects.[11]
Incomplete auxiliary inputs for importation assessment: Passenger volumes, traveller occupations, deployment rosters, medevac activity, and country-specific laboratory and referral readiness were incomplete; country ratings were therefore comparative judgements rather than calibrated probabilities.[124]
Counting intervals understating true uncertainty: Notification rates remain composite measures of infection, care seeking, alert investigation, specimen transport, laboratory capacity, retrospective death investigation, and reporting; the exact Poisson intervals are therefore deliberately described as counting-model intervals rather than complete epidemiological uncertainty intervals.[125]
CFR interpretation caution: The rise in confirmed-case CFR is compatible with maturation of outcomes among previously active cases, retrospective confirmation of deaths, delayed presentation, preferential detection of severe disease, delayed recovery reporting, and changes in testing or death investigation; it should not be interpreted as a time-resolved measure of clinical virulence.[126]
Unresolved status discrepancy in DRC counts: The published status totals did not fully reconcile — 828 deaths, 390 recoveries, and 725 hospitalised patients summed to 1,943, leaving 181 of 2,124 confirmed cases outside those categories — and public reports did not define the status of these cases; potential explanations include pending admission or outcome reconciliation, transfers, and reporting lags, but no category could be assigned without line-list data.[127]
Time-stamped analysis: The analysis was time-stamped and may be superseded by subsequent official reports.[128]
Data sources¶
Primary outbreak data: Public surveillance reports from WHO, ECDC, Africa CDC, national ministries of health, and peer-reviewed sources were synthesised through 15–17 July 2026.[129] The main DRC trajectory used laboratory-confirmed cases and deaths among confirmed cases; suspected, probable, and confirmed categories were not summed across reports because individuals and deaths can be reclassified as investigations progress.[130] Uganda’s official dashboard as of 17 July reported 20 confirmed cases, two confirmed deaths, 18 recoveries, and no current admissions.[131] WHO’s jurisdictional accounting on 17 July comprised 2,145 confirmed cases globally: 2,124 in the DRC, 20 in Uganda, and one in France, with 830 confirmed-case deaths.[132]
Auxiliary data: Peer-reviewed primary studies were used for historical BDBV outbreaks, viral persistence, and candidate countermeasures.[133] Airline sources were used only to establish the existence of plausible routes and not to estimate passenger volumes.[110] ECDC Monte Carlo importation summaries (approximately one importation per 23,000–24,000 travellers, with 90% uncertainty interval one per 13,000–54,000) were referenced as separately generated estimates and were not treated as exact reciprocals.[134][135]
Fanelli et al. (5 Jul 2026) Importation risk and preparedness priorities across Africa in the 2026 Bundibugyo Ebola outbreak¶
Overview¶
This analysis estimates the risk of Bundibugyo Ebola virus disease (BVD) importation from the ongoing outbreak in eastern DRC and Uganda to all other African countries, and contextualizes that risk against each country’s epidemic readiness. The authors developed an integrated spatial framework combining high-resolution epidemic and population data, air and land mobility, geographical accessibility, and conflict-adjusted travel times, then contextualized importation risk using national readiness indicators.[136] Importation risk was highly geographically concentrated, with neighbouring countries accounting for 85% of continental risk; South Sudan, Rwanda, Kenya, Tanzania, Zambia, Ethiopia, Burundi, Angola, South Africa, the Central African Republic, and Nigeria were estimated at high risk, with the largest readiness gaps in South Sudan, Burundi, and the Central African Republic.[137]
Estimate¶
This analysis does not estimate total outbreak size (case counts). Its primary output is relative importation risk — the estimated probability that an infected traveller from the affected areas reaches each African country — stratified by destination country, mobility pathway, and readiness. Key findings are as follows.
The 11 countries in the high-risk quartile — South Sudan, Rwanda, Kenya, Zambia, Ethiopia, Tanzania, Burundi, Angola, South Africa, Central African Republic, and Nigeria — accounted for 93% of the total estimated importation risk, forming a largely contiguous regional belt surrounding the affected area, with Ethiopia, South Africa, and Nigeria at greater geographic distance (border distance 2, 3, and 3 from the outbreak source, respectively).[138]
Neighbouring countries alone accounted for 85% of the total estimated risk, while countries located two border crossings away contributed an additional 9%.[139]
Ethiopia, South Africa, and Nigeria were the only non-neighbouring countries classified as high risk overall; each ranked substantially higher for air importation risk than land importation risk — Ethiopia ranked first for air but fifth for land, South Africa third and ninth, and Nigeria seventh and eleventh.[140]
Under amplification scenarios, the ranking of high-risk countries remained largely unchanged across the seven scenarios tested, with South Sudan, Rwanda, Kenya, Tanzania, and Zambia remaining among the five countries at highest risk.[5] Amplification in Nairobi and Lusaka produced the largest increase in continental importation (4-fold), and up to 15-fold in southern Africa; amplification in Kampala and Kigali produced a moderate increase (2.5-fold and 2.8-fold, respectively), whereas expansion to Kinshasa, Bujumbura, or Juba produced comparatively limited continental effects.[141]
Methods¶
Integrated multi-layer importation risk model: The authors developed an integrated analytical framework combining epidemiological and high-resolution spatial population data, commercial air transportation, land mobility, geographical accessibility, conflict-adjusted travel times, and different readiness scores to estimate the risk of Ebola Bundibugyo dissemination across Africa.[142] Importation risk for each African country was estimated separately for air and land mobility as the probability that an infected traveller from the affected areas would reach that country, assuming infected cases could travel only during the latent (pre-symptomatic) phase; for land mobility, travel times were incorporated to estimate the destination reached before symptom onset, while air journey times were considered negligible relative to the incubation period.[143] Risks were weighted by the cumulative attack rate in each affected administrative unit, and air and land importation risks were then combined into an overall relative importation risk per destination country.[144]
Air mobility component: Air mobility was derived from IATA data on origin–destination passenger flows between any pair of commercial airports, accounting for connections at intermediate airports.[145] Population in each administrative unit was assigned to airports using weights proportional to population size and decreasing with distance to each airport.[146]
Land mobility component: Land mobility was obtained as residual mobility by subtracting air mobility from the Global Transnational Mobility Dataset 2.0 (GTMD2), which provides estimates of overall population movements between countries.[147] To characterize spatial accessibility and potential for land-based spread within the incubation period, travel-time surfaces were computed using a global motorized-travel friction surface integrating road networks, land cover, rivers, topography, and transport infrastructure, estimated from each affected health district and ADM3 unit to all destination countries, and adjusted for conflict-related disruptions using ACLED data calibrated against Google Maps driving-time estimates.[148] The share of population in each unit travelling to each destination country was estimated through a gravity model calibrated on observed land mobility patterns.[149] Sensitivity analyses reduced land mobility by 66% and 90% and varied assumed daily driving time beyond the baseline of 8 hours; these produced only limited changes in country rankings and no changes in the estimated geography of risk.[150]
Readiness contextualization: National epidemic readiness was assessed using the WHO SPAR (2025), the Global Health Security Index (GHS, 2021), the Infectious Disease Vulnerability Index (IDVI, 2016), and the Epidemic Risk Index (INFORM-WHO, 2020), with indicators on healthcare system capacity and emergency preparedness and response extracted from each framework.[151] SPAR was selected as the primary readiness metric given its complete coverage of African countries, recent update, and direct relevance to the WHO Framework for Health Emergency Preparedness and Response Capabilities.[152] GHS indicators were used in sensitivity analyses.[153]
Amplification scenarios: Amplification scenarios were designed to assess potential impact of epidemic expansion beyond the currently affected area into highly connected urban centres, including the capital cities of DRC (Kinshasa) and Uganda (Kampala), and the capitals of neighbouring high-risk countries: Juba, Kigali, Bujumbura, Nairobi, and Lusaka.[154]
Reporting-rate adjustment: To account for geographically heterogeneous reporting rates, the authors used the proportion of alerts investigated among reported alerts in each DRC province, averaged over the two weeks preceding 5 July 2026, relative to 100% reporting in Uganda, and explored alternative values in sensitivity analysis.[155]
Assumptions¶
Latent-phase travel only: The analysis assumed that Ebola-infected cases could travel only during their latent (pre-symptomatic) phase, as symptomatic patients would be expected to either remain in the affected country for clinical management or, if transferred internationally, travel under medically supervised and controlled conditions.[156] This is consistent with the rapid onset of symptoms and progressive clinical deterioration characteristic of Ebola virus disease; however, the authors acknowledge that some individuals with early or mild symptoms may still travel before seeking care, particularly over shorter distances, potentially increasing importation risk to more distant destinations.[157]
Homogeneous travel behaviour: The analysis assumed homogeneous travel behaviour and exposure risk across travellers, although age, occupation, socioeconomic conditions, purpose of travel, and individual exposure may modify infection risk, as illustrated by the imported case in France involving a medical doctor working in the response.[10]
Reporting rate proxy: To account for geographically heterogeneous under-ascertainment, the proportion of alerts investigated among reported alerts in each DRC province over the two preceding weeks was used as a proxy for local reporting rates, relative to 100% reporting assumed for Uganda; alternative values were explored in sensitivity analysis.[155] Geographically heterogeneous under-ascertainment is difficult to quantify, though the results were found to be robust to alternative assumptions.[158]
Land travel duration and daily driving time: Land-mediated importation risk was estimated assuming an average travel duration of 8 hours per day; alternative travel durations produced no changes in the estimated geography of risk.[159]
Border restrictions excluded: Border restrictions and closures related to the current outbreak were not modelled because implemented measures were partial, temporary, and largely limited to official points of entry, and available cross-country mobility data suggested no meaningful reduction in cross-border movement occurred during such restrictions.[160]
Air travel restricted to commercial passenger flights: Air-mediated importation risk only considered commercial passenger flights and did not account for humanitarian, military, or charter flights.[23]
Attack rate weighting: Importation risks were weighted by the cumulative attack rate in each affected administrative unit[161], meaning areas with higher local epidemic intensity contribute proportionally more to estimated exportation risk.
SPAR as primary readiness metric: SPAR was selected as the primary epidemic readiness metric because of its complete coverage of African countries, recent update (2025), and direct relevance to the current WHO Framework for Health Emergency Preparedness and Response Capabilities; GHS indicators were used in sensitivity analyses.[152]
Limitations¶
Scarcity of land mobility data: Reliable data on cross-border land mobility in Africa remain scarce; land mobility was therefore estimated from the best available continental dataset, combining multiple mobility sources and deriving land movements as the residual after discounting commercial air travel.[162] Sensitivity analyses reducing land mobility by 66% and 90% produced only limited changes in country rankings, supporting robustness, though uncertainty remains.[163]
Restricted analysis to contiguous Africa: The analysis was restricted to contiguous Africa because comparable data on maritime mobility are not available.[164]
Commercial flights only: Air-mediated importation risk only considered commercial passenger flights and did not account for humanitarian, military, or charter flights.[23]
Homogeneous travel behaviour and exposure risk: The assumption of homogeneous travel behaviour and exposure risk across travellers does not capture variation by age, occupation, socioeconomic conditions, purpose of travel, or individual exposure.[10]
Under-ascertainment difficult to quantify: Geographically heterogeneous under-ascertainment is difficult to quantify; the proportion of investigated alerts was used as a proxy, and results were found to be robust to alternative assumptions.[158]
Border control measures not modelled: Behavioural adaptations and the impact of border control measures were not explicitly modelled; while some border restrictions were implemented, independent mobility data suggested no measurable change in cross-border movements, and evidence from previous Ebola outbreaks highlights that travel restrictions have limited impact on spatial dissemination while potentially hampering response activities.[165]
Readiness indicators are structural, not operational: Recent outbreak experience demonstrates that operational preparedness is not solely determined by structural readiness indicators[166], and the readiness scores used (SPAR, GHS, IDVI, INFORM) may not fully capture in-the-moment operational capacity built through experience and regional coordination.
Data sources¶
Primary outbreak data: Cumulative confirmed cases were obtained from the INSP DRC daily situation report number 51 (published 5 July 2026) and the Uganda Ministry of Health update of 5 July 2026.[167] As of 4 July 2026, the outbreak had reached 1,561 confirmed cases in Ituri, North Kivu, and South Kivu provinces in DRC, and 20 confirmed cases in Uganda.[3]
Auxiliary data — population: Population data for DRC were obtained from the 2024 health-zone population projections produced by the DRC Information Management Working Group and disseminated by OCHA through the Humanitarian Data Exchange Platform.[168] For Uganda, population estimates at administrative levels 0–3 were obtained from UNFPA, based on Uganda Bureau of Statistics data.[169]
Auxiliary data — air mobility: Air mobility was derived from IATA data on origin–destination passenger flows between any pair of commercial airports, accounting for connections at intermediate airports.[145]
Auxiliary data — land mobility: Land mobility was obtained from the Global Transnational Mobility Dataset 2.0 (GTMD2), which provides estimates of overall population movements between countries, with air mobility subtracted to yield the land component.[147]
Auxiliary data — conflict and travel time: Travel times were adjusted for conflict-related disruptions using the most recent conflict data at ADM2 level from the Armed Conflict Location & Event Data Project (ACLED), calibrated against Google Maps driving-time estimates.[170]
Auxiliary data — readiness indicators: National readiness was assessed using the WHO SPAR (2025), the GHS Index (2021), the IDVI (2016), and the INFORM-WHO Epidemic Risk Index (2020).[171]
Auxiliary data — reporting rates: Geographically heterogeneous reporting rates were proxied by the proportion of alerts investigated among reported alerts in each DRC province, averaged over the two weeks preceding 5 July 2026.[172]
Gashema & Muvunyi (8 Jun 2026) Can stochastic modelling predict cross-border spread of the Bundibugyo Ebola virus outbreak in Africa?¶
Overview¶
A modelling study by Dick Chamla and colleagues uses fitted stochastic SEIRD (susceptible, exposed, infectious, recovered, deceased) ensemble modelling to leverage limited data to predict cross-border outbreak spread and inform regional preparedness.[173] The analysis estimates the probability of regional spillover to neighbouring countries, finding a high probability of spread to Uganda (94.2%) and South Sudan (69.3%), while projected risks for Rwanda (8.6%) and Burundi (2.0%) remain comparatively low.[25] By linking outbreak dynamics with spillover risk, the analysis moves beyond forecasting disease burden toward informing operational preparedness.[174]
Estimate¶
The central estimates of regional spillover probability are: Uganda 94.2%, South Sudan 69.3%, Rwanda 8.6%, and Burundi 2.0%.[25] These are presented as point estimates of spillover probability rather than case counts or incidence figures. No uncertainty bounds, confidence intervals, or sensitivity ranges around these probabilities are reported in this document. No outbreak size estimate (case count or incidence) is provided.
Methods¶
Fitted stochastic SEIRD ensemble modelling: The analysis describes a stochastic susceptible, exposed, infectious, recovered, and deceased (SEIRD) ensemble modelling approach developed by Chamla and colleagues, fitted to limited outbreak data to predict cross-border outbreak spread.[173] The method produces country-level spillover probability estimates for Uganda, South Sudan, Rwanda, and Burundi. The method is described only at a high level in this commentary; no calibration procedure, specific parameter values, or detailed description of how mobility or epidemiological inputs are incorporated are provided in the document reviewed here.
Assumptions¶
Homogeneous mixing and uniform intervention effectiveness: The stochastic models assume homogeneous population mixing and uniform intervention effectiveness, potentially overlooking important spatial, health-care, and socioeconomic heterogeneities that shape transmission dynamics.[175]
Data quality and mobility approximations: Projections are constrained by the quality of early surveillance data and approximated mobility patterns, particularly in low- or limited-resource settings where data gaps are common.[176]
Static behavioural assumptions: The models are limited in their ability to capture behavioural adaptation and community engagement, including changes in risk perception, health-care-seeking behaviour, intervention uptake, and public trust, all of which can substantially influence outbreak trajectories.[177]
Detection delay: An estimated 6-week interval between the probable index case and formal outbreak declaration is noted, representing an undetected transmission window that shapes the model’s starting conditions.[178]
Limitations¶
Incomplete information during evolving outbreaks: Models developed during unfolding outbreaks inevitably operate under conditions of incomplete information, evolving surveillance systems, and changing response capacities, which can affect their ability to accurately predict transmission dynamics. Accordingly, these models are not intended to provide a precise forecast, but rather to identify reasonable transmission trajectories and inform preparedness decisions.[179]
Homogeneous mixing assumption: Stochastic models assume homogeneous population mixing and uniform intervention effectiveness, potentially overlooking important spatial, health-care, and socioeconomic heterogeneities that shape transmission dynamics.[175]
Data quality and mobility data gaps: Projections are further constrained by the quality of early surveillance data and approximated mobility patterns, particularly in low- or limited-resource settings where data gaps are common.[176]
Behavioural dynamics not captured: The models remain restricted in their ability to capture behavioural adaptation and community engagement, including changes in risk perception, health-care-seeking behaviour, intervention uptake, and public trust, all of which can substantially influence outbreak trajectories.[177]
Scenario-based estimates requiring continuous refinement: These limitations underscore the importance of interpreting model outputs as scenario-based estimates that require continuous refinement as more comprehensive epidemiological, mobility, and behavioural data become available.[180]
Data sources¶
The document does not specify the primary outbreak data sources or auxiliary data inputs used in the Chamla and colleagues modelling study in sufficient detail to enumerate them. The study is described as integrating epidemiological, laboratory, and mobility data into real-time risk assessments.[181] Projections are noted to be constrained by early surveillance data and approximated mobility patterns, particularly in low- or limited-resource settings where data gaps are common,[176] but specific dataset names, time periods covered, or sample sizes are not provided in this commentary.
Chamla et al. (8 Jun 2026) Size of the 2026 Ebola outbreak and risk of cross-border spillover from Bundibugyo virus in Ituri Province, DR Congo, and its implications for preparedness: a recalibrated stochastic modelling study¶
Overview¶
This analysis aims to establish a short-term epidemic trajectory of the 2026 BDBV outbreak and quantify the probability of cross-border spillover into neighbouring countries at elevated importation risk, to guide preparedness priorities. It uses a stochastic SEIRD ensemble model calibrated to laboratory-confirmed DRC cases, anchored at 598 cumulative confirmed cases on 8 June 2026, linked to a daily-hazard spillover model estimating importation probability for Uganda, South Sudan, Rwanda, and Burundi over a 12-week horizon.[182][183] Under the central scenario (R0 = 1.71), the model projects a median of 990 cumulative confirmed cases by week 12 (24 June 2026; 90% PI 709 to 1,293) and 174 deaths, with cross-border importation probabilities of 94.2% for Uganda, 69.3% for South Sudan, 8.6% for Rwanda, and 2.0% for Burundi.[184][4]
Estimate¶
Central scenario (R0 = 1.71): The ensemble projects a median of 648 cumulative confirmed cases by week 10 (8 June 2026; 50% PI 560 to 732), rising to 990 by week 12 (24 June 2026; 50% PI 858 to 1,141 and 90% PI 709 to 1,293), with a projected median of 174 deaths at week 12.[185] By week 24, the central scenario projects a median of 8,210 cumulative confirmed cases (50% PI 6,636 to 10,287 and 90% PI 5,063 to 13,498) and approximately 1,440 deaths if transmission is merely sustained.[186]
Low-transmissibility scenario (R0 = 1.42): Cumulative confirmed cases reach a median of 870 by week 12 (50% PI 752 to 1,004 and 90% PI 641 to 1,133; 160 deaths) and 3,662 by week 24 (50% PI 2,884 to 4,484 and 90% PI 2,094 to 6,037; 673 deaths).[187]
High-transmissibility scenario (R0 = 2.08): Confirmed cases reach a median of 1,364 (50% PI 1,154 to 1,579 and 90% PI 975 to 1,807; 202 deaths) by week 12, rising to 66,420 (50% PI 56,560 to 78,937 and 90% PI 41,718 to 95,881; 10,644 deaths) by week 24.[188]
Because the observed confirmed-case trajectory is consistent with the central scenario, the high scenario is not the operative trajectory; it is retained as an upper-bound contingency should control measures lapse.[189]
Spillover estimates: Cross-border importation probabilities over the 12-week horizon are: Uganda 94.2%; South Sudan 69.3%; Rwanda 8.6%; and Burundi 2.0%.[4]
Methods¶
Stochastic SEIRD ensemble model: A discrete-time stochastic SEIRD (susceptible, exposed, infectious, recovered, dead) framework using binomial draws under standard mass-action incidence, applied to the affected health zones in Ituri and North Kivu provinces. No vaccinated compartment is included, as no licensed BDBV-specific vaccine exists.[190][191] Three transmissibility scenarios are modelled (low R0 = 1.42; central R0 = 1.71; high R0 = 2.08), with response-intensity reductions applied from 15 May 2026 of 20% (low), 25% (central), and 15% (high).[192][193] Calibration was performed by simulation filtering (approximate rejection sampling, not formal Bayesian inference), accepting replicates if cumulative laboratory-confirmed cases at day 68 fell within ±30% of 598 (range 419 to 777); 400 calibration-passing replicates per scenario were retained.[194]
Daily-hazard spillover model: Importation risk to Uganda, South Sudan, Rwanda, and Burundi was modelled as a daily Poisson hazard driven by calibrated infectious prevalence, country-specific cross-border mobility, point-of-entry detection sensitivity from WHO Joint External Evaluation assessments, and travel-while-infectious parameters (Uganda 12%; South Sudan 15%; Rwanda and Burundi 8%), with full equations and parameter values given in appendix 3.[195] The importation probability for each country is computed as 1 − exp(cumulative 12-week hazard), yielding the probability of at least one importation over the horizon.[196] Sensitivity analyses examined travel-while-infectious (5% to 25%), reporting completeness (0.60 to 0.90), and catchment size (250,000 to 500,000).[197]
Assumptions¶
Transmissibility (R0): Three scenarios span published BDBV estimates from the 2007 Uganda and 2012 DR Congo outbreaks: low R0 = 1.42, central R0 = 1.71, and high R0 = 2.08.[192][198] The confirmed-case trajectory is described as most consistent with the central scenario.[199]
Delay distributions: The latent period is fixed at 9.7 days and the infectious period at 5.0 days, in line with the broader filovirus literature.[200]
Case-fatality ratio: Drawn from a uniform distribution (0.15 to 0.25), centred on the observed confirmed-case ratio of approximately 19% (115 of 598 as of 8 June 2026) and consistent with the historical BDBV range.[201]
Reporting fraction: Set at 1.0 for laboratory-confirmed cases, on the basis that laboratory-confirmed cases are by definition ascertained; no separate suspected-case reporting fraction is assumed.[202]
Response effectiveness: The model incorporates a transmission reduction factor representing the combined effects of IPC measures, community engagement, safe and dignified burial, and contact tracing, with reduction factors varying by scenario to reflect differing operational effectiveness from the date of outbreak declaration onward.[203] The response-intensity factor was applied uniformly from 15 May, though real-world response effectiveness varies by place, time, access, and community acceptance.[204]
Spatial structure: The model assumes a homogeneously mixing catchment of 350,000 across seven affected health zones; spatial heterogeneity is not captured, which is stated as a limitation.[205]
Cross-border spillover parameters: Importation hazard is driven by calibrated infectious prevalence, country-specific cross-border mobility, WHO Joint External Evaluation–derived point-of-entry detection sensitivity, and travel-while-infectious parameters fixed at 12% for Uganda, 15% for South Sudan, and 8% for Rwanda and Burundi. These parameters were not empirically derived for this outbreak and represent the principal sources of uncertainty in spillover projections.[206][207] Varying travel-while-infectious from 5% to 25% changes Uganda’s importation probability by less than 5 percentage points (saturating at the upper end) but alters South Sudan’s projected importation probability by approximately 20 percentage points.[208]
Calibration procedure: Simulation filtering (approximate rejection sampling) is used rather than formal Bayesian inference; the ±30% tolerance window was chosen pragmatically given residual data uncertainty.[209][210]
Limitations¶
Spatial homogeneity and model structure: Homogeneous mixing oversimplifies spatial heterogeneity across health zones; healthcare-worker transmission was not separately modelled; and response intensity was applied uniformly across the catchment rather than varying by subgeography or population group.[211]
Single-point calibration anchor: The model is anchored on a single recent confirmed-case datum (598 on 8 June 2026), making the fit sensitive to that anchor value.[211]
Informal inference procedure: Simulation filtering is not formal inference, and informal cross-border mobility estimates are imprecise.[211]
Response uniformity: The response-intensity factor was applied uniformly from 15 May, but real-world response effectiveness varies by place, time, access, and community acceptance. Live mobility data and behavioural adaptation were not incorporated.[212]
Surveillance and reporting dynamics: Post-declaration case-finding surges probably contributed to rapid apparent growth between 15 and 19 May; the authors addressed this by lowering the reporting fraction and widening the calibration window, but residual confounding between transmission intensity and surveillance intensity remains.[213]
Early data quality: Calibration relied on early-phase surveillance counts from the first weekly WHO External Situation Report (data as of 18 May), where the cumulative suspected-case figure of 528 was only partially resolved into 35 laboratory-confirmed cases, and the death count of 132 reflected surveillance signals rather than laboratory-confirmed mortality alone. Misclassification, delayed laboratory throughput, and ongoing active case finding could each shift the calibration anchor in either direction.[214]
Exploratory rather than definitive projections: The projections require iterative recalibration as new data emerge, and should be interpreted as an early situational assessment rather than a definitive forecast.[215][216]
Absence of sex and gender disaggregation: Individual-level sex and gender data were not available in the aggregate surveillance reports, making disaggregated analysis by sex or gender impossible.[217]
Data sources¶
Primary outbreak data: Case data were taken from WHO AFRO External Situation Reports and the WHO AFRO internal tracker through to 8 June 2026. The laboratory-confirmed case series used as the primary calibration metric rose from 33 cases on 18 May 2026 to 105 on 24 May 2026, and 598 on 8 June 2026.[218] Uganda reported seven confirmed cases (three imported; four locally acquired, including three healthcare workers) as of 24 May 2026.[219] As of 4 June 2026, Uganda reported 19 confirmed cases, including five healthcare-worker infections and two deaths.[220]
Auxiliary data: Country-specific point-of-entry detection sensitivity was drawn from WHO Joint External Evaluation assessments.[206] The three R0 values (1.42, 1.71, 2.08) were chosen to span the range of published BDBV estimates from the 2007 Uganda and 2012 DR Congo outbreaks.[192][198] The latent period (9.7 days) and infectious period (5.0 days) were taken from the broader filovirus literature.[200] The case-fatality ratio was drawn from a uniform distribution (0.15 to 0.25), centred on the confirmed-case ratio observed in the current outbreak (approximately 19%; 115 of 598 as of 8 June 2026) and consistent with the historical BDBV range.[201] Travel-while-infectious and cross-border mobility parameters were not empirically derived for this outbreak and represent the principal sources of uncertainty in spillover projections.[207]
Walekhwa et al. (5 Jun 2026) Network-based modelling of Bundibugyo Ebola virus disease importation and spread in Uganda using Displacement Tracking Matrix flow data¶
Overview¶
This analysis aims to quantify district-level importation and spread risk of the 2026 Bundibugyo virus disease outbreak in Uganda, originating from the ongoing DRC epidemic, in order to inform where surveillance and response resources should be concentrated. It constructs a data-driven directed weighted mobility network from IOM Displacement Tracking Matrix flows (11,245 observed movements, 15–24 May 2026) and the 2024 Uganda census, then runs a stochastic metapopulation SEIR model over 90 days across 135 Ugandan districts and two DRC provinces.[221] Under the containment scenario, the model projects a median of 22 cumulative cases (95% CrI: 22–24) and 2 deaths concentrated entirely in Kampala over 90 days, with all other 134 districts projecting a median of 0 cases, and no statistically significant reduction from adding non-pharmaceutical interventions at any compliance level.[222]
Estimate¶
Under the containment scenario (effective R = 0.35), the model projected a median of 22 cumulative cases (95% CrI: 22–24) and 2 deaths (95% CrI: 2–4) over 90 days, all concentrated in Kampala, with 3 HCW infections and 0 HCW deaths; 95% credible intervals overlapped substantially across compliance scenarios, indicating no statistically significant difference between them.[223]
Kampala was the only district with a non-zero median projection, bearing a predicted burden of 22 cases (95% CrI: 22–24) and a 100% probability of a local outbreak (>10 cases); all other 134 districts had a median of 0 predicted cases, with upper credible intervals extending to 1 in only a small fraction of simulations.[224]
The three compliance scenarios corresponded to the following parameterisations: containment (effective R₀ = 0.35, mobility scale 0.05), moderate compliance (R₀ = 0.40, mobility scale 0.08), and low compliance (R₀ = 0.45, mobility scale 0.12).[225] Across all three scenarios, the median total case count remained 22, with no scenario producing a statistically distinct outcome.
Methods¶
Directed weighted mobility network: Both undirected and directed weighted networks were built from DTM flow data using the igraph package in R; for the directed network, original flow directions were preserved to allow separate computation of in-strength (import risk) and out-strength (export risk) for each node, covering all 135 Ugandan districts and two DRC provinces.[226] To impute 12-month movement estimates from the 10-day observed flows, observed weights were multiplied by 36.5, and uncertainty from the limited sampling window was assessed via bootstrap resampling with 1,000 replicates.[227]
Stochastic metapopulation SEIR model: A discrete-time stochastic SEIR model is maintained at the node (district) level, with five compartments — Susceptible, Exposed, Infectious, Recovered, Dead — a latent period of 7.5 days, and an infectious period of 8.5 days.[228] Pre-symptomatic transmission is modelled by setting the relative infectiousness of exposed individuals to 0.5 compared to infectious individuals, based on estimates from early EVD outbreaks and the empirical observation that six secondary cases in Kampala tested positive while under quarantine.[229] The baseline transmission rate was derived from R₀ = 2.76, calibrated to the early growth of the outbreak (16 cases in 21 days).[230] DRC provinces were modelled as explicit nodes with their own SEIR dynamics, recalibrated to actual reported data as of May 25, 2026 (381 confirmed cases, 2,987 exposed contacts, and 64 deaths).[231] The model was run for three NPI compliance scenarios (20%, 40%, 60%) with 1,000 stochastic simulations each. The 7-1-7 agile response was explicitly modelled with dynamic contact tracing coverage (40% → 70% → 85%).[232]
Sobol global sensitivity analysis: To quantify the influence of parameter uncertainty on total cumulative case count, a global sensitivity analysis using the Sobol method was performed, with first-order indices measuring variance explained by each parameter alone and total-order indices measuring variance including all interactions.[233] The design used quasi-random Sobol sequences with N = 500 samples (6,500 model evaluations total), with each parameter set averaged over 3 stochastic replicates to reduce noise, and Sobol indices estimated with 200 bootstrap replicates for 95% confidence intervals.[234]
Assumptions¶
Mobility data representativeness and scaling: The DTM flow data covering a 10-day period are assumed to be representative of average daily movement patterns after scaling by 36.5 to impute annual estimates.[235] Movement is assumed independent each day (no memory), with only exposed and infectious individuals moving, and the probability of moving identical for both compartments.[236] The analysis acknowledges that movements through unofficial crossings or after the outbreak escalated may not be captured, a limitation common to mobility-based epidemiological studies.[237]
Transmission parameters: The latent period is fixed at 7.5 days and the infectious period at 8.5 days.[238] The baseline transmission rate is derived from R₀ = 2.76, calibrated to the early growth of the outbreak (16 cases in 21 days).[230] Pre-symptomatic infectiousness is set at 0.5 relative to fully infectious individuals, based on estimates from early EVD outbreaks and the observation that six secondary cases tested positive while under quarantine.[229]
Case fatality and healthcare worker attack rates: The CFR (2/20 = 0.10) and HCW attack rate (3/20 = 0.15) are assumed constant throughout the simulation.[239] The DRC CFR is fixed at 64/381 = 0.168, based on reported outbreak data.[240]
Detection and isolation: A detection delay of 3 days is assumed to apply uniformly to all infected individuals, and quarantine after detection is assumed perfect — isolated individuals no longer transmit.[241] Reported incidence uses a detection probability of p_detect = 1.0, assuming all symptomatic cases are detected.[242]
DRC epidemic independence: The DRC epidemic curve is assumed to be independent of Uganda’s interventions and to drive importations solely through the movement matrix.[243] DRC response parameters reflect a moderately delayed response: detection delay 7 days (based on the 2018–2020 DRC outbreak), notification delay 3 days, response delay 5 days, contact tracing coverage 30%, detection probability 0.7, and no behavioural response.[244]
NPI compliance and homogeneity: Compliance with NPIs is assumed constant over the 90 days and homogeneous across districts.[245]
Geographic scope of importations: No importations from countries other than DRC are considered.[246]
Superspreading: New infections are drawn from a negative binomial distribution to capture superspreading, with dispersion parameter k_disp = 0.3.[247]
Homogeneous mixing within districts: The homogeneous mixing assumption within districts likely overestimates transmission in low-density areas and underestimates it in high-density slums.[248]
Limitations¶
Mobility data coverage and temporal representativeness: The DTM data cover only a 10-day window and eight border crossing points; movements through unofficial crossings or after the outbreak escalated may not be captured. While annual estimates are imputed using time-dependent decay, real mobility patterns can change unpredictably.[17]
Homogeneous mixing within districts: The homogeneous mixing assumption within districts likely overestimates transmission in low-density areas and underestimates it in high-density slums.[248]
Unstable Sobol confidence intervals from small outbreak size: The Sobol confidence intervals for some parameters remained wide because the small outbreak size (median 22 cases) produces low output variance, making precise quantitative ranking unstable; the authors therefore interpret the Sobol results qualitatively as ranking parameter importance rather than providing precise quantitative estimates.[249]
Hospital and funeral transmission not explicitly modelled: Hospital and funeral transmission are not explicitly modelled, a limitation given that Legrand et al. (2007) identified nosocomial transmission and unsafe burials as major amplifiers in Ebola outbreaks.[250]
No importations from countries other than DRC: Importations from neighbouring countries other than DRC were not considered, though the 79.9% importation risk estimated by Chalma et al. (2026) focused specifically on DRC-origin introductions.[251]
Data sources¶
Primary outbreak data: The Uganda Ministry of Health EVD situation report as of June 5, 2026 provided initial outbreak conditions: 15 cumulative cases (plus 1 probable), 2 deaths, 5 recoveries, 720 cumulative contacts listed (455 active under follow-up), with all initial cases located in Kampala under institutional quarantine.[252] DRC model initialisation used actual reported data as of May 25, 2026 — 381 confirmed cases, 2,987 exposed contacts, and 64 deaths — with Nord-Kivu initialised at 4,000 exposed and 400 infectious individuals, and Ituri at 500 exposed and 50 infectious.[253]
Auxiliary data — mobility: The IOM DTM Flow Monitoring report covering 15–24 May 2026 summarised cross-border movements from DRC into Uganda and internal movements among Ugandan districts; 11,245 total observed individuals were distributed across eight Flow Monitoring Points: Ntoroko Main (28%), Mpondwe (18%), Busunga (18%), Bunagana (12%), Cyanika (8%), Goli (8%), Vurra (3%), and Busanza (3%).[254]
Auxiliary data — demographic: The official 2024 Uganda Population and Housing Census final report (UBOS, December 2024) provided the de facto population for each of the 135 districts, totalling 45,905,417.[255]
Auxiliary data — parameters from prior outbreaks and literature: Previous BVD outbreaks in Uganda (2007–08; 131 confirmed cases, 42 deaths) and DRC (2012; 38 confirmed cases, 13 deaths) informed background on transmissibility and CFR, with R₀ estimates ranging from 1.2 to 2.6.[256] Bangelesa et al. contributed Flowminder-based mobility intensity index data for Ituri Province (March 2025–March 2026), covering all 340 DRC health zones; Ituri had the second highest average MII nationally (25.3), with epicentre zones Rwampara (68.6), Bunia (62.6), and Mongbwalu (49.9) all exceeding the 95th national percentile.[257]
Okingo, Iroungou, & Valdano (4 Jun 2026) Introduction and sustained-transmission risk across DRC health zones during the Bundibugyo virus disease outbreak¶
Overview¶
This analysis estimates introduction risk and sustained-transmission potential for each health zone (HZ) across the DRC during the ongoing Bundibugyo virus disease outbreak, with the goal of identifying priority zones — including those far from currently affected areas — where rapid amplification could follow an introduction and where response efforts should be focused.[258] The approach applies a published method to rank all DRC health zones by their sustained-transmission potential, using population and mobility data to parameterise spatial transmission across a broad range of assumptions on disease transmissibility and contact patterns, then compares these ranks with introduction-risk ranks estimated from mobility data.[259] The main finding is that eight health zones combine both high introduction risk and high sustained-transmission potential: Binza Ozone and Binza Meteo in Kinshasa; Karisimbi in Nord-Kivu; Kadutu and Ibanda in Sud-Kivu; and Makiso-Kisangani, Kabondo, and Mangobo in Tshopo.[260]
Estimate¶
This analysis does not report outbreak size estimates (e.g., total case counts or incidence figures). Introduction risk was highest in health zones close to the reported foci — specifically in Ituri, Nord-Kivu, and Haut-Uele — consistent with expected mobility patterns, with non-negligible introduction risk also appearing in distant urban centres including the Kinshasa area.[261] High sustained-transmission potential was distributed broadly across DRC, including Kinshasa, Kasaï-Oriental, Kongo-Central, Tshopo, Nord-Kivu, Haut-Katanga, Sud-Kivu, Kasaï, and Kasaï-Central — several of which are far from the current outbreak.[262] Crossing the two rankings identified eight health zones combining high introduction risk and high sustained-transmission potential: Binza Ozone and Binza Meteo in Kinshasa; Karisimbi in Nord-Kivu; Kadutu and Ibanda in Sud-Kivu; and Makiso-Kisangani, Kabondo, and Mangobo in Tshopo.[260] No point probabilities, quantitative thresholds, or numerical uncertainty intervals are reported in the main text.
Methods¶
Sustained-transmission potential ranking: This method applies the approach developed in a previously published reference (Ref. 2) to estimate, for each DRC health zone, the potential for an introduced case to generate sustained transmission.[263] Population and mobility data are used to parameterise spatial transmission, and a broad range of assumptions on disease transmissibility and on how local and between-community contact patterns can be inferred from these data are tested.[264] Population data come from WorldPop and mobility data from FlowMinder.[265]
Introduction-risk ranking: Introduction risk is estimated separately for each DRC health zone using mobility data, and health zones are ranked by this measure.[266] Risk rankings — rather than raw risk estimates — are emphasised because they are robust across scenarios and assumptions, allowing them to inform action despite limited knowledge of transmissibility and contact patterns.[267]
The two rankings (sustained-transmission potential and introduction risk) are then crossed to identify health zones that score highly on both dimensions.[266] The method is described only briefly in the main text; full methodology, additional data sources, and additional results are stated to be in an Appendix.
Assumptions¶
Transmissibility and contact patterns: The analysis tests a broad range of assumptions on disease transmissibility and on how local and between-community contact patterns can be inferred from population and mobility data. Specific parameter values are not reported in the main text and are described as available in the Appendix.[264]
Ranking robustness: A structural assumption central to the analysis is that risk rankings — as opposed to raw risk estimates — are robust across scenarios and assumptions, and that this robustness justifies using rankings to inform action despite limited knowledge of transmissibility and contact patterns. This is stated as a key design choice rather than a tested sensitivity.[267]
Data availability: The analysis is explicit that it operates under limited data on human mobility, contact patterns, disease transmissibility, and tracing and isolation capacity; these constraints shape what can be estimated and drive the reliance on ranking rather than point estimates.[268]
Mobility and population data: Spatial transmission is parameterised using WorldPop population data and FlowMinder mobility data. No statement is made about the vintage, resolution, or representativeness of these datasets for the current outbreak context.[265]
Limitations¶
Limited input data: The analysis is explicit that it operates under limited data on human mobility, contact patterns, disease transmissibility, and tracing and isolation capacity, all of which are required to fully characterise introduction and sustained-transmission risk.[268]
Structural outbreak challenges not modelled: Insecurity, high population mobility, limited healthcare capacity, and the absence of a vaccine are cited as challenges to response. The analysis does not indicate whether these factors are formally incorporated into the model or treated as qualitative context.[269]
Heterogeneous preparedness: The analysis acknowledges heterogeneous healthcare access, accessibility constraints, and low-to-moderate insecurity outside Kinshasa as factors affecting response feasibility in identified high-risk zones, but these are discussed qualitatively rather than incorporated into the quantitative framework.[270]
Appendix-dependent detail: Methodology, additional data sources, and additional results are available only in the Appendix, which is not reproduced in the main document. The main text provides insufficient detail to assess specific parameter choices, calibration procedures, or sensitivity analyses.[271]
Data sources¶
Primary outbreak data: The analysis references the ongoing BVD outbreak in Ituri province, DRC, with confirmed cases in Nord-Kivu and Sud-Kivu noted as of June 4 as evidence of geographic spread beyond the initial focus. No surveillance line list, case count, or situation report data are described as direct model inputs in the main text.[272][273]
Auxiliary data: Population data are from WorldPop (worldpop.org) and mobility data are from FlowMinder (flowminder.org).[265] The sustained-transmission potential method is drawn from a previously published reference (Ref. 2), used as the methodological foundation.[263] Additional data sources are stated to be available in the Appendix, which is not reproduced in the main document.[271] No travel volume sample sizes, demographic inputs, or epidemiological parameters (e.g., CFR, serial interval) are reported in the main text.
Kinoshita, Suzuki, & Yoneoka (4 Jun 2026) Early assessment of potential airline-mediated importation risk during the 2026 DRC-Uganda Bundibugyo virus disease outbreak¶
Overview¶
This analysis projects potential airline-mediated importation risk during the 2026 BVD outbreak in DRC and Uganda, using a contemporary airline network dataset and an importation hazard parameter calibrated from historical Ebola outbreak data.[274] The approach converts airline passenger-flow connectivity into country-level arrival probabilities over a defined time horizon. The main finding identifies major international hub countries — Belgium, France, South Africa, Kenya, and the United Arab Emirates — as the highest-probability destinations for potential importation until the end of June 2026.[6]
Estimate¶
This analysis produces importation probability estimates rather than outbreak size estimates. Airport-level arrival probabilities, interpreted as the probability of at least one airline-mediated importation until the end of June 2026 (t = 44), ranged from 0.247 to 0.937, with a mean of 0.431.[275] Higher arrival probabilities were concentrated among airports with shorter effective distances from FIH and stronger connectivity through major transit hubs: for example, 0.889 at Brussels Airport, 0.888 at Paris Charles de Gaulle Airport, and 0.871 at Johannesburg O.R. Tambo International Airport.[276] The highest country-level arrival probabilities were observed for Belgium, France, South Africa, Kenya, and the United Arab Emirates, with the top-ranked countries all exceeding 0.77; in sensitivity analyses the probabilities for these countries ranged from 0.38 to 0.98.[277] When the starting airport is changed to EBB (Uganda) in sensitivity analysis, the mean (standard deviation) of arrival probability ranged from 0.170 (0.049) to 0.616 (0.099).[278]
Methods¶
Effective-distance airline importation model: Potential airline-mediated importation risk was projected using a hazard-based model informed by contemporary airline transportation networks and a hazard parameter calibrated from the 2013–2016 West African Ebola virus disease epidemic, one of the few EBOD outbreaks with documented long-distance airline-mediated international exportations.[279] A directed, weighted air-traffic network was constructed using airport-level origin-destination passenger-flow data from OAG for May 2024, comprising 11,264 airports, 569,741 routes, and 329,326,078 passengers.[280] The shortest-path effective distance from FIH to each destination airport was computed using Dijkstra’s algorithm on the directed network.[281] The arrival hazard at each destination airport was modelled as λⱼ = θ/Dⱼ (where θ = 0.19, the primary hazard parameter), and the arrival probability within t days was computed as pⱼ(t) = 1 − exp(−tλⱼ).[282] Country-level arrival risk was summarized as the maximum airport-level probability within each country.[283] Sensitivity analyses tested θ = {0.06, 0.32} based on the 95% confidence interval of the historical parameter estimate.[284] An additional sensitivity analysis varied the effective-distance scaling parameter δ using epidemic growth rates r = {0.034, 0.05, 0.1} estimated as of 17 May 2026.[285]
Assumptions¶
Transferability of historical hazard parameter: The model assumes that the relationship between effective distance and EVD importation observed during the 2013–2016 West African epidemic is transferable to the current BVD outbreak. The estimated effective distance distribution was reported as very similar to that of the previous study, which the authors cite as supporting use of the same θ value on a comparable hazard scale.[286]
Effective-distance scaling: In the main analysis, the distance-scaling parameter δ is set to 1, assuming each additional travel step contributes one unit of distance (the Brockmann-Helbing scale), which has been empirically shown to predict global spread patterns of infectious diseases.[287] An alternative δ formulation incorporating the epidemic growth rate and outbound passenger flow from FIH is tested in sensitivity analysis, but the authors note this increases uncertainty.[288]
Hazard parameter sensitivity: The primary hazard value θ = 0.19 is varied to {0.06, 0.32} (the 95% CI bounds of the historical estimate) in sensitivity analyses. These sensitivity runs change absolute arrival probabilities but broadly preserve the overall geographic pattern, because effective distance determines the spatial pattern while the hazard parameter mainly scales the probabilities.[284][289]
Static airline network: The estimates rely on 2024 airline network data and therefore may not capture subsequent changes in routes, passenger volumes, airspace restrictions, or travel advisories, including those affecting routes through Russia and the Middle East.[290]
No post-PHEIC interventions: The projections do not explicitly account for post-PHEIC interventions, enhanced screening, or behavioural changes.[291]
Source airport scope: The analysis models global air travel originating from FIH as the primary source, treating EBB only in sensitivity analysis, and does not explicitly account for land-based spread within DRC or cross-border movements to neighbouring countries.[292]
Importation versus transmission: Estimated arrival probability is interpreted as importation risk rather than the risk of local transmission after arrival, on the basis that EBOD requires direct contact with infectious body fluids or contaminated materials, and that timely detection, isolation, contact tracing, and infection prevention and control can reduce onward transmission.[293]
Limitations¶
Reliance on a borrowed, cross-pathogen hazard parameter: Because no airline-mediated importation had been reported as of 28 May 2026, the hazard parameter was estimated from the 2013–2016 West African EVD epidemic rather than from current BVD data, and the model assumes this historical relationship is transferable to the present outbreak.[294]
Static airline data and absence of intervention effects: The projections rely on May 2024 airline network data and therefore may not capture subsequent route changes, passenger volume shifts, airspace restrictions, travel advisories, or the effect of post-PHEIC interventions, enhanced screening, and behavioural changes.[295]
Geographic scope limited to air travel from two airports: The analysis focuses on global air travel originating from FIH, with EBB considered only in sensitivity analysis, and does not explicitly account for land-based spread within DRC or cross-border movements to neighbouring countries.[292]
Importation risk only, not local transmission risk: Estimated arrival probability should be interpreted as importation risk rather than the risk of local transmission after arrival.[296] Countries with high-probability airport gateways should therefore be interpreted as priorities for awareness and preparedness, rather than as locations where local outbreaks are expected.[297]
Increased uncertainty in alternative δ formulation: The sensitivity analysis δ formulation incorporates the epidemic growth rate and outbound passenger flow, but the authors note that while this adds information about the current epidemic situation, it also increases uncertainty.[288]
Data sources¶
Primary outbreak data: Epidemiological context was drawn from publicly available reports: as of 4 June 2026, DRC had reported 363 confirmed cases including 62 deaths, and Uganda had reported 15 confirmed cases including one death.[298] Because no airline-mediated importation had been reported as of 28 May 2026, no exported-case numerator was available to calibrate the current-outbreak hazard.[299]
Auxiliary data: Airline passenger-flow data came from OAG (a global travel data provider listed in the IATA Strategic Partners Directory) for May 2024, covering 11,264 airports, 569,741 routes, and 329,326,078 passengers.[280] The importation hazard parameter (θ = 0.19) was calibrated from the 2013–2016 West African EVD epidemic and applied here as the primary value.[279][300] Epidemic growth rate estimates (r = {0.034, 0.05, 0.1}) used in sensitivity analyses were taken as of 17 May 2026.[285]
Richard et al. (2 Jun 2026) Assessment of Risk to the U.S. Population from the Ebola Disease Outbreak Caused by Bundibugyo Virus, 2026¶
Overview¶
In response to the BVD outbreak in DRC and Uganda, CDC assessed the risk posed by the outbreak to the U.S. population over the next 3 months, using a standardized risk assessment approach that drew on epidemiologic data from the ongoing outbreak and historical data from previous Ebola outbreaks.[301] The overall risk was determined by independently assessing two factors: the likelihood of infection and the impact of infection.[302] The assessment found that the overall risk to the U.S. population is low, based on an extremely low likelihood of transmission, despite the high impact that potential infection could have and the resources that would be required to respond.[303]
Estimate¶
The overall risk posed by the ongoing BVD outbreak to the U.S. population during the next 3 months is assessed as low, with moderate confidence given the data available.[31] This overall risk reflects a combination of an extremely low likelihood of infection and a high impact of infection for the U.S. population were it to occur.[304]
The relative risk of importation to the United States compared with other locations was estimated at 1.3%[305], derived from the population movement model. No quantitative uncertainty bounds are provided for this figure.
The impact of infection was assessed as high, primarily based on the severity of illness, lack of available medications and vaccines, and resources required to respond; in the two previously identified BVD outbreaks (Uganda 2007 and DRC 2012), case-fatality rates ranged from 25% to 50%.[306]
No outbreak size estimate (total case count or under-detection factor) is reported. The analysis does not produce a central estimate with confidence intervals for total cases.
Methods¶
Standardized qualitative risk assessment framework: CDC subject matter experts in risk assessment methodology, infectious disease modeling, global health, and Ebola disease collaborated using a standardized risk assessment approach that has been applied to previous viral hemorrhagic fever outbreaks, drawing on available evidence including epidemiologic data from the ongoing BVD outbreak and historical data on Bundibugyo virus and other Ebola disease outbreaks.[307] The overall risk to the U.S. population was determined by independently assessing two factors: the likelihood of infection (i.e., the probability that members of the U.S. population would acquire Bundibugyo virus infection during the next 3 months, depending on likelihood of exposure, infectiousness, and susceptibility) and the impact of infection (i.e., consequences including disease severity, population immunity, availability of medications and vaccines, and necessary public health response resources).[308] Experts then assigned a degree of confidence to the assessment, taking into account evidence quality, extent, and corroboration of information.[309]
Population movement model for importation risk: The likelihood of spread from DRC to the United States via infected travelers was assessed using a model that considers population movement; this produced a relative risk of importation to the United States compared with other locations of 1.3%.[310] The method is described only briefly; no calibration procedure, parameter values, or data source for the mobility inputs are specified in the document.
Assumptions¶
Importation likelihood: The current likelihood of potential spread of BVD from DRC to the United States via travelers who might be infected is considered very low based on modeling results that consider population movement.[311] The specific structural assumptions, parameter values, and data inputs underlying this model are not disclosed in the document.
Secondary transmission in the United States: If BVD were introduced into the United States, secondary transmission would likely be minimal, based on historical observation and the known epidemiology of BVD.[312] This assumption relies on the known property that persons are not infectious before symptom onset and that the average interval between cases is long (10–16 days), making public health measures highly effective.[313]
Population scope: Risk is assessed only for the general U.S. population, with subpopulations potentially having different likelihood assessments noted separately.[314] Specifically, the likelihood of infection is judged to be higher among U.S. health care workers practicing in or recently returned from affected regions in DRC and Uganda.[315]
Case fatality and clinical outcomes: CFRs of 25%–50% from previous BVD outbreaks are used to characterize disease severity, but the analysis notes that many of those deaths occurred in resource-limited settings and that clinical outcomes might improve with the specialized care available in the United States.[316]
Outbreak trajectory: The assessment acknowledges uncertainties about the epidemiology of BVD, the scope and geographic spread of the outbreak, and the potential timelines for implementation of interventions, all of which represent assumptions embedded in the risk tier assigned.[317]
Limitations¶
Limited prior outbreak experience: Given that only two previous BVD outbreaks have occurred, less is known about Bundibugyo virus than other orthoebolaviruses such as O. zairense, which constrains the evidence base for the assessment.[318]
Incomplete outbreak scope: Limited confirmatory diagnostic testing and challenges in contact tracing have likely resulted in undetected transmission, meaning the full scope of the current outbreak is unclear, making it difficult to assess the potential geographic spread of the outbreak and the subsequent potential for spread to the United States.[319]
Operational and contextual challenges: Several features of this outbreak pose challenges to assessing its future trajectory, including that the outbreak is occurring in a region with ongoing conflict and unpredictable infrastructure, and the initial large size of the outbreak combined with limited confirmatory diagnostic testing may lead to challenges in infection prevention and control efforts.[320]
General uncertainty: The assessment recognizes uncertainties around the epidemiology of BVD as well as the current and future scope and geographic spread of the outbreak.[321]
Data sources¶
Primary outbreak data: As of June 2, 2026, a total of 378 confirmed BVD cases and 63 deaths reported in DRC and Uganda, drawn from the two countries’ surveillance systems.[322]
Auxiliary data: Historical data on Bundibugyo virus and other Ebola disease outbreaks were used to inform the assessment.[323] Specifically, case-fatality rates from the two previous BVD outbreaks in Uganda (2007) and DRC (2012), ranging from 25% to 50%, were referenced.[324] Historical observation of Ebola disease treatment and secondary transmission in the United States, specifically the 2014–2016 West African outbreak during which only 11 persons with Ebola disease were treated in the United States and no community spread occurred, was also used.[325] Modeling results considering population movement informed the relative importation risk estimate of 1.3% for the United States compared with other locations.[310] No specific dataset names, sample sizes for auxiliary sources, or mobility data sources are identified in the document.
Fanelli et al. (29 May 2026) Shifting patterns of importation risk of Bundibugyo Ebola virus disease to Europe under outbreak expansion scenarios¶
Overview¶
Using International Air Transport Association (IATA) origin-destination passenger flows, this analysis estimates the relative risk of Bundibugyo virus disease importation into Europe under six outbreak expansion scenarios reflecting plausible pathways of geographical spread, including cross-border transmission and amplification in highly connected regional capitals.[326] Relative exposure patterns across European countries remained largely unchanged under localized transmission in eastern DRC and border-spillover scenarios, but expansion into South Sudan generated a first structural increase in importation pressure to Europe, while hypothetical amplification in Kampala, Kigali, and Kinshasa substantially increased importation pressure and reshaped exposure patterns.[7] Across all scenarios, France, Italy, and the United Kingdom remained among the most exposed countries.[327]
Estimate¶
This analysis does not produce an outbreak size estimate (i.e., a count of cases or infections). Its outputs are relative importation risk rankings for European countries and fold-change increases in importation pressure by European subregion under each scenario. Potential spread across the Ugandan border produced no change in either the relative exposure of European countries or their overall importation pressure compared with the currently reported localized transmission in eastern DRC, with Italy, France, Belgium, and the UK being the most exposed.[328] Expansion to South Sudan produced a first structural increase in importation pressure through Juba (5-fold increase for Northern Europe and 6-fold increase for Eastern Europe relative to localized DRC transmission), while still leaving the UK, France, and Italy among the highest-risk countries.[329] Kampala and Kigali amplification increased exposure in Northern Europe, with Kampala producing a >120-fold increase in importation pressure relative to localized DRC transmission; Kinshasa amplification primarily reinforced exposure in Western Europe (~80-fold increase).[330] In the sensitivity analysis using full-year 2024 travel data, the Kampala amplification scenario produces approximately 190-fold increase for Northern Europe.[331]
Methods¶
Air-travel importation risk model using IATA origin-destination flows: The analysis uses origin-destination passenger flows derived from the 2024 IATA database, which captures complete passenger itineraries including traffic travelling via connecting flights rather than only direct flight segments.[332] The relative importation risk to each European country is estimated as the proportion of total outgoing passenger flow from the selected seed airports directed to that country, where passenger flow from each origin airport in a given scenario is summed across all destination airports in the receiving country, then normalized to total passenger flow from source airports to all of Europe.[333] Risks are then stratified by European subregion.[334] This approach produces relative (not absolute) importation risk rankings and does not incorporate incubation period, detection probability, or infectious prevalence at source. A sensitivity analysis using average monthly data from the full year 2024 was conducted to account for potential seasonal effects; results were broadly consistent with the main analysis, with the exception of the Kampala amplification scenario, in which the increase in importation pressure for Northern Europe rises to approximately 190-fold when using full-year monthly averages.[335]
Assumptions¶
Proportional travel as a proxy for importation risk: The model assumes that the relative proportion of outbound passenger volume from seed airports to each European country is a valid proxy for relative importation risk. The relative importation risk to each destination country is estimated purely as the share of total outgoing passenger flow from the selected seed airports directed to that country, normalized to all Europe-bound flow.[333] This structural assumption means that no adjustment is made for incubation period, probability of travelling while infectious, detection at exit or entry, or per-capita incidence at source — the analysis is explicitly relative, not absolute.
Scenario seeding and airport selection: The six scenarios are designed to reflect plausible pathways of geographical spread from the currently affected area through porous borders.[336] Each scenario’s result depends entirely on which airports are included as seeds: adding or removing an airport changes the importation ranking. The analysis does not specify how the airport catchment areas were defined or how ground-to-air connectivity within source regions was accounted for.
Travel data representativeness: The analysis uses cumulative passenger traffic from May, June, and July 2024; this period showed moderate seasonal variability, with mean volumes ranging from 3% below to 16% above the monthly 2024 average across scenarios.[337] The analysis implicitly assumes 2024 travel patterns are representative of 2026 patterns during the outbreak period, including any travel disruptions or demand changes associated with the outbreak itself.
Capital-city amplification as a hypothetical: Scenarios 4–6 explore hypothetical amplification assuming community transmission in major urban hubs — Kampala, Kigali, and Kinshasa.[338] The analysis does not assign probabilities to these scenarios occurring; they are treated as illustrative of what importation pressure would look like if amplification did occur, rather than as probabilistic forecasts.
Limitations¶
Relative risk only, no absolute importation probability: The analysis produces relative rankings and fold-change comparisons but does not estimate the absolute probability that any infected traveller departs or arrives at a given destination. Patterns of importation risk to Europe may rapidly shift under uncertainty surrounding the geographical extent and evolution of the outbreak, particularly if transmission expands into major urban hubs with strong international connectivity near the affected area.[339] The analysis does not quantify this uncertainty in probabilistic terms.
Seasonal and temporal representativeness of travel data: The analyses use cumulative passenger traffic from May, June, and July 2024, a period that showed moderate seasonal variability relative to the 2024 annual average.[337] The authors do not discuss whether outbreak-related changes in travel behaviour (e.g., reduced tourism or business travel to affected regions) would alter the estimates.
No adjustment for detection, infectious period, or per-capita incidence: The method does not incorporate incubation period distributions, probability of travelling while infectious, exit or entry screening effectiveness, or source-area incidence rates. As a consequence, all scenarios implicitly assume equal per-traveller exportation risk from each seed airport, which the authors do not explicitly flag as a limitation but is a direct consequence of the proportional-flow methodology.
Hypothetical nature of amplification scenarios: Scenarios 4–6 explore hypothetical amplification assuming community transmission in major urban hubs.[338] The analysis does not assign likelihoods to these scenarios or model the transmission dynamics required to reach that state, limiting their direct operational applicability.
Data sources¶
Primary outbreak data: As of 29 May 2026, the outbreak involved 125 confirmed cases (17 deaths) and 906 suspected cases (223 deaths) across Ituri, North Kivu, and South Kivu provinces in Eastern DRC, and 9 confirmed cases (1 death) in Uganda.[340] These figures inform the scenario definitions (which areas to include as seeds) but are not directly used as a quantitative input to the model formula.
Auxiliary data: Origin-destination passenger flows are derived from the 2024 IATA database, which captures complete passenger itineraries including connecting flights.[332] Analyses are based on cumulative passenger traffic reported for May, June, and July 2024.[341] Relative to annual traffic to Europe, mean passenger volumes during May–July ranged from 3% below to 16% above the monthly 2024 average across scenarios.[342] No line list, demographic data, or parameters borrowed from prior outbreaks are used as model inputs; the method relies solely on the IATA travel volumes and the airport-level scenario seeding definitions.
van Zandvoort et al. (20 May 2026) The risk of global Ebola virus spread is low: epidemiology of Ebola disease cases outside Africa, 1976 to May 2026¶
Overview¶
This analysis reviews the historical record of confirmed Ebola disease cases presenting outside Africa to contextualize the intercontinental spread risk posed by the 2026 Bundibugyo virus disease (BVD) outbreak in DRC. The authors conducted internet searches — both manual and AI-assisted — to identify all laboratory-confirmed Ebola disease cases presenting outside Africa, without any time limit.[343] The main finding is that intercontinental transmission risk remains low, based on the full historical record of such cases.[344]
Estimate¶
The analysis does not produce an outbreak size estimate for the 2026 BVD outbreak itself. Instead it reports importation risk metrics derived from the historical record.
The crude overall risk since 2000 is 0.81 cases outside Africa per 1,000 Ebola disease cases in a source outbreak (including medically evacuated, latent, and secondary cases); focusing on latent cases and their secondary cases only, the rate is 0.17 cases outside Africa per 1,000 source outbreak cases.[345] This represents the empirically observed risk across all countries outside Africa combined; per-country risks are smaller — for example, for the UK alone, the estimate is 0.03 latent cases per 1,000 source outbreak cases.[346]
From the time-varying analysis of the 2014–16 epidemic, exportation risk per reported source case decreased by 4.6% per week (95% CI: 1.7–7.4%; p = 0.0097), and was substantially lower after the epidemic peak (0.46; 95% CI: 0.17–0.73 exported cases per 1,000 source cases) than before it (1.7; 95% CI: 0.95–2.7 exported cases per 1,000 source cases).[347]
Methods¶
Historical case review and crude risk calculation: The authors identified and analysed all known Ebola disease cases outside Africa to contextualise intercontinental spread, using manual and AI-assisted internet searches of scientific articles, public health bulletins, and news reports.[348] As a crude risk measure, they calculated the number of cases occurring outside Africa per 1,000 reported cases in the originating epidemic for outbreaks since 2000, producing separate estimates including and excluding medically evacuated cases.[349] This calculation applies globally across all destination countries outside Africa combined, with a UK-specific example provided at the national level.
Time-varying Poisson regression: For cases exported from the 2014–16 West African epidemic specifically, the authors conducted a time-varying risk analysis using Poisson regression of the weekly count of exported cases by country (Guinea, Liberia, Sierra Leone) against the number of cases reported that week and a linear time trend.[350] This produced an estimate of how exported case counts scaled with source-country incidence, with no significant deviation from linear scaling found.[351] This method applies to the 2014–16 epidemic as a historical comparator and is not applied directly to the 2026 BVD outbreak.
Assumptions¶
Linear scaling of exportation risk with source incidence: The Poisson regression assumes that exported case counts scale linearly with weekly source-country incidence, an assumption the analysis found consistent with the 2014–16 data (estimated scaling: 0.98; 95% CI: 0.60–1.36; p = 0.86).[351] This assumption underpins the use of crude per-1,000-cases risk ratios to project forward.
Crude risk ratio as applicable across outbreaks: The crude risk measure is calculated for Ebola disease outbreaks since the year 2000[13], implicitly assuming that the historical ratio of exported-to-source cases is informative for the current 2026 BVD outbreak. The analysis does not explicitly state whether this assumption holds given differences in travel patterns, response capacity, or the specific virus species involved.
Distinction between medically evacuated and latent cases: The analysis distinguishes between medically evacuated cases, who represent known risks manageable with strict biosecurity, and latent cases arriving via commercial flights who need to be diagnosed before isolation.[352] The risk ratios are computed separately for these two categories, with the latent-only figure treated as the more policy-relevant measure of uncontrolled importation risk.
Completeness of historical case ascertainment: Agreement among search methods and with a prior clinical review supports that the case list is likely complete, but potential under-ascertainment may arise from underrepresentation of public health bulletins not published in English, and from possible geographic biases in web-based search tools.[353]
Limitations¶
Potential under-ascertainment of exported cases: Public health bulletins not published in English were underrepresented despite targeted native-language searches, and web-based search tools may have returned geographically biased results, potentially leading to missed cases.[354]
Historical data may not reflect current outbreak conditions: The analysis applies risk ratios derived primarily from the 2014–16 West African epidemic — a very large, prolonged epidemic with substantial international humanitarian response — to the 2026 BVD context. The authors note that the decrease in exportation risk over the 2014–16 epidemic is likely most consistent with improvement in infection prevention and control measures coinciding with the stepping-up of response efforts in late 2014[355], but do not formally assess whether this dynamic applies to the current, structurally different outbreak.
Per-country risks not estimated: The crude risk estimate represents the empirically observed risk across all countries outside Africa; per-country risks are smaller[356], and the analysis provides only the aggregate outside-Africa figure plus a single UK example, without ranking or estimating risk for individual destination countries.
Latent case detection depends on screening: The four latent cases identified occurred among 300,000 screened travellers and were all asymptomatic at exit and entry screening; their eventual identification relied on screening protocols that included guidance on self-monitoring of symptoms.[357] The analysis does not assess what the latent case rate would have been in the absence of such protocols.
Data sources¶
Primary outbreak data: The analysis identified 28 confirmed Ebola disease cases outside Africa in total, of which 27 occurred during the 2014–16 West African epidemic and one has occurred so far during the 2026 BVD epidemic.[358] Sources consulted included 27 scientific articles, 9 public health bulletins, 82 news articles, and 9 other sites.[359]
Auxiliary data: Weekly case counts for Guinea, Liberia, and Sierra Leone (total 28,592 confirmed, probable, and suspected cases) covering the 2014–16 epidemic were used as the source-country incidence series in the Poisson regression.[360] The authors also reference the approximately 300,000 travellers screened by CDC-supported exit screening programmes in Guinea, Liberia, and Sierra Leone during the 2014–16 epidemic, as context for the four identified latent cases.[361] Findings were checked against existing lists of Ebola disease cases.[362]
References¶
Bouhentala, O.W. and Kadir, M.Y. (2026) ‘Epidemiological analysis of the 2026 Bundibugyo virus disease outbreak and rapid risk assessment for North Africa and Europe’, medRxiv [Preprint]. doi: 10.64898/2026.07.19.26358411.
Chamla, D., Belizaire, M.R.D., Co, I.F., Jinadu, A., Mamadu, I. and Atagbaza, A.O. (2026) ‘Size of the 2026 Ebola outbreak and risk of cross-border spillover from Bundibugyo virus in Ituri Province, DR Congo, and its implications for preparedness: a recalibrated stochastic modelling study’, The Lancet Infectious Diseases. Online first. doi: 10.1016/S1473-3099(26)00320-8.
Epistorm (2026). Ebola Bundibugyo Virus — DRC · Spread Risk Assessment · International Dissemination. Available at: https://
epistorm .github .io /EBV2026 /Report6RR .html (Accessed 8 August 2026). Fanelli, F., Parino, F., Pelle, M.A., Wang, B., Boum, Y., Fallah, M., Mbala, P., Okingo, R.L., Ronin, V., Yazdanpanah, Y., Poletto, C., Valdano, E. and Colizza, V. (2026a) ‘Importation risk and preparedness priorities across Africa in the 2026 Bundibugyo Ebola outbreak’, medRxiv [Preprint]. doi: 10.64898/2026.07.21.26358330.
Fanelli, F., Parino, F., Poletto, C. and Colizza, V. (2026b) ‘Shifting patterns of importation risk of Bundibugyo Ebola virus disease to Europe under outbreak expansion scenarios’, medRxiv [Preprint]. doi: 10.64898/2026.05.31.26354511.
Gashema, P. and Muvunyi, C.M. (2026) ‘Can stochastic modelling predict cross-border spread of the Bundibugyo Ebola virus outbreak in Africa?’, The Lancet Infectious Diseases. Online first. doi: 10.1016/S1473-3099(26)00352-X.
Kinoshita, R., Suzuki, M. and Yoneoka, D. (2026) ‘Early assessment of potential airline-mediated importation risk during the 2026 DRC-Uganda Bundibugyo virus disease outbreak’, medRxiv [Preprint]. doi: 10.64898/2026.06.01.26354569.
Okingo, R.L., Iroungou, B.A. and Valdano, E. (2026) ‘Introduction and sustained-transmission risk across DRC health zones during the Bundibugyo virus disease outbreak’, medRxiv [Preprint]. doi: 10.64898/2026.06.11.26355237.
Richard, D.M., Routledge, I., Koeller, S. et al. (2026) ‘Assessment of risk to the U.S. population from the Ebola disease outbreak caused by Bundibugyo virus, 2026’, MMWR Morbidity and Mortality Weekly Report, 75, pp. 290–292. doi: 10.15585/mmwr.mm7522e2.
van Zandvoort, K., Procter, S.R., Azam, J.M., Sherratt, K. and Davies, N.G. (2026) ‘The risk of global Ebola virus spread is low: epidemiology of Ebola disease cases outside Africa, 1976 to May 2026’, Eurosurveillance, 31(24), 2600508. doi: 10.2807/1560-7917.ES.2026.31.24.2600508.
Verheyden, J.G.L. and Mudogo, C.N. (2026) ‘Incidence-weighted force of infection for predicting first reported health-zone cases during the 2026 Bundibugyo virus disease outbreak: a rolling-origin evaluation’, medRxiv [Preprint]. doi: 10.64898/2026.08.12.26360244.
Walekhwa, A.W., Mbaka, P., Nannyonga, B.K., Silal, S.P., Bbuye, M., Nakiire, L., Lamorde, M., Suilamon, T.A., Kwesiga, B., Sabiiti, W., Turinawe, G., Nakazibwe, B., Kayiwa, J., Nantongo, M., Ipola, P.A., Kungu, P., Ario, A.R., Kagirita, A., Lubwama, B., Kirenga, B.J., Muruta, A.N., Olaro, C. and Atwine, D. (2026) ‘Network-based modelling of Bundibugyo Ebola virus disease importation and spread in Uganda using Displacement Tracking Matrix flow data and non-pharmaceutical intervention compliance scenarios’, medRxiv [Preprint]. doi: 10.64898/2026.06.22.26356210.
Methods overview
These pages are produced by a semi-automated evidence-synthesis pipeline that pairs AI models with human review at each major checkpoint: one model reads each source analysis on its own and grounds every extracted claim in a verbatim quoted passage; a second model takes the resulting structured comparison as input, and drafts the narrative. Human analysts then review and edit the output to ensure accuracy and completeness prior to publishing.
Identifying analyses. Analyses are identified through continuous monitoring of preprint servers, peer-reviewed publications, and grey literature. An analysis is included if it directly addresses the 2026 Bundibugyo virus disease (BVD) outbreak and provides a quantitative estimate relevant to a given topic (e.g., outbreak size, risk of spread). Each included source is logged, and if the authors later release an updated version, the newer version supersedes the earlier one.
Preparing the source text. Each source text, regardless of source type (e.g., PDF, HTML), is converted to Markdown. A human analyst then curates the converted file and removes sections that carry no evidentiary content, such as references, acknowledgments, author contributions, affiliations, and declarations of interest, to keep extraction focused and reduce the number of input tokens used.
Extracting structured evidence. The curated text is split into individually citeable units, one per sentence, and passed to Claude Sonnet 4.6. For each of a fixed set of dimensions (e.g., estimates, methods, limitations), the model answers from that one source alone and must ground every factual claim in a verbatim span of its text.
Synthesizing the narrative. OpenAI’s GPT-5.5 model reads the dimensions extracted for each analysis and synthesizes the information, covering the state of the evidence, how the estimates compare and why they diverge, the key uncertainties and assumptions shared across analyses, what would most reduce that uncertainty, and what it implies for the response.
Human review and publication. Human analysts edit the draft for accuracy, completeness, and tone prior to publishing.
Limitations. This pipeline surfaces only publicly available analyses; works that have not been made public are not captured.
World Health Organization (2026) “Disease Outbreak News, 14 August 2026”: "Since the previous Disease Outbreak News was published on 1 August 2026, additional confirmed cases and deaths of BVD have been only reported in the Democratic Republic of the Congo. Cumulatively as of 12 August 2026, 4686 confirmed cases have been reported: 4665 in the Democratic Republic of the Congo (including two cases diagnosed in the Democratic Republic of the Congo and subsequently treated in Germany), 20 in Uganda and one in France. "
Epistorm (2026) “Methods Overview”: “Following the 2 June 2026 reopening of the Bunia International Airport, this update factors increased domestic and regional mobility from the affected area into the model. The full footprint covers Ituri, North Kivu, South Kivu, and Uganda, reflecting the laboratory-confirmed travel-related case in Bukavu (South Kivu) and the 19 laboratory-confirmed cases in Uganda.”
Fanelli et al. (2026a) “INTRODUCTION”: “As of 4 July 2026, the outbreak — previously declared a Public Health Emergency of International Concern (PHEIC) — has reached 1,561 confirmed cases across the provinces of Ituri, North Kivu, and South Kivu in eastern DRC, and 20 confirmed cases in Uganda.”
Chamla et al. (2026) “Summary”: “Cross-border spillover remained material: Uganda 94.2% importation probability (19 confirmed cases as of 4 June 2026, including five healthcare-worker infections and two deaths); South Sudan 69.3%; Rwanda 8.6%; and Burundi 2.0%.”
Fanelli et al. (2026a) “RESULTS”: “Across the seven scenarios tested, the ranking of high-risk countries remained largely unchanged and closely matched that estimated under the current epidemic spread. Specifically, South Sudan, Rwanda, Kenya, Tanzania, and Zambia remained among the 5 countries at highest risk of importation (Fig. 4a).”
Kinoshita, Suzuki, & Yoneoka (2026) “Abstract”: “Effective-distance analyses identified major international hub countries, including Belgium, France, South Africa, Kenya, and the United Arab Emirates, as higher-probability gateways until the end of June, 2026.”
Fanelli et al. (2026b) “Abstract”: “Relative exposure patterns remained largely unchanged under localized transmission in eastern DRC and border-spillover scenarios. Expansion into South Sudan generated a first structural increase in importation pressure to Europe through the connectivity associated with Juba, while hypothetical amplification in Kampala, Kigali, and Kinshasa substantially increased importation pressure and reshaped exposure patterns across Europe.”
Okingo, Iroungou, & Valdano (2026) “Body”: “These results separate importation from amplification risk: health zones near the affected area are more likely to receive cases, but not necessarily to sustain transmission. Our estimates therefore differ from Ref. 5 by identifying areas of concern farther from the affected zone.”
Okingo, Iroungou, & Valdano (2026) “Body”: “Our results warrant preparedness in health zones with high sustained-transmission potential but lower introduction risk, particularly in Kinshasa and other urban centers, despite their distance from the outbreak. This is relevant because several high-amplification areas are in Kinshasa, Kasaï, and Tshopo, where preparedness may be more feasible than in parts of eastern DRC despite heterogeneous healthcare access, accessibility constraints, and low-to-moderate insecurity outside Kinshasa.”
Fanelli et al. (2026a) “DISCUSSION”: “We also assumed homogeneous travel behaviour and exposure risk across travellers, although age, occupation, socioeconomic conditions, purpose of travel, and individual exposure may modify infection risk, as illustrated by the imported case in France involving a medical doctor working in the response.”
Bouhentala & Kadir (2026) “4. Discussion”: “The main limitation is dependence on public aggregate data. Reporting dates do not represent symptom onset, and the analysis could not estimate time-varying reproduction numbers, serial intervals, onset-to-isolation delays, household secondary-attack rates, health-zone-specific growth, or intervention effects.”
Verheyden and Mudogo (2026) “4 Discussion”: “The outcome modelled throughout is first reported confirmed case, not the unobserved date of viral introduction. These differ to the extent that introduction, local transmission, detection, testing access, and reporting capacity differ across zones, and we cannot separate these mechanisms with the data available. This matters specifically for the health-facility-density covariate, whose positive association with hazard may partly or wholly reflect greater detection capacity in better-served zones rather than, or in addition to, genuinely greater introduction risk.”
van Zandvoort et al. (2026) “Low overall risk of exportation”: “As a crude measure of risk, we calculated for Ebola disease outbreaks since the year 2000 the number of cases occurring outside Africa per 1,000 reported cases in the originating epidemic.”
Chamla et al. (2026) “Discussion”: “Future iterations should integrate line lists, contact-tracing data and dynamic mobility estimates.”
Bouhentala & Kadir (2026) “4. Discussion”: “Reporting dates do not represent symptom onset, and the analysis could not estimate time-varying reproduction numbers, serial intervals, onset-to-isolation delays, household secondary-attack rates, health-zone-specific growth, or intervention effects.”
Fanelli et al. (2026a) “DISCUSSION”: “First, reliable data on cross-border land mobility in Africa remain scarce.”
Walekhwa et al. (2026) “4. Discussion”: “The DTM data cover only a 10-day window and eight border crossing points; movements through unofficial crossings or after the outbreak escalated may not be captured, a limitation common to mobility-based epidemiological studies. While we imputed annual estimates and used time-dependent decay, real mobility patterns can change unpredictably.”
Walekhwa et al. (2026) “4. Discussion”: “Real-time updating, running the model weekly with new DTM data and case counts, would transform this retrospective analysis into a prospective decision support tool, as advocated by Kraemer et al. (2018) for real-time epidemic response.”
Chamla et al. (2026) “Discussion”: “Although South Sudan’s importation probability is lower than Uganda’s, documented deficits across all five WHO preparedness domains mean any importation would generate a substantially larger secondary outbreak. Closing these gaps within 4 to 8 weeks is the principal operational window.”
Fanelli et al. (2026a) “ABSTRACT”: “Anticipating where imported infections are most likely to occur, and whether recipient countries are prepared to detect and contain them, is essential for prioritizing surveillance and response.”
Fanelli et al. (2026a) “DISCUSSION”: “Our approach provides an operational framework for refining preparedness priorities, updating them as outbreaks evolve and medical countermeasures become available, and anticipating changes before regional dissemination accelerates.”
Fanelli et al. (2026a) “DISCUSSION”: “However, some individuals with early or mild symptoms may still travel before seeking care, particularly over shorter distances, potentially increasing importation risk to more distant destinations.”
Fanelli et al. (2026a) “DISCUSSION”: “Third, air-mediated importation risk only considered commercial passenger flights and did not account for humanitarian, military, or charter flights.”
Walekhwa et al. (2026) “4. Discussion”: “The practical implication is that early outbreak response should include rapid estimation of the infectious period and serial interval for the specific Ebola strain. Investing in field studies to characterise these biological parameters, through contact tracing data and serial interval analysis, could yield greater returns than refining operational protocols that are already performing adequately, a strategy advocated by Chowell et al. (2019) for Ebola preparedness.”
Gashema & Muvunyi (2026) “Considering epidemiological and contextual factors, the study estimated a high probability of regional spillover to Uganda (94·2%) and South Sudan (69·3%), identifying these countries as priority areas for preparedness. By contrast, the projected risks for Rwanda (8·6%) and Burundi (2·0%) remain comparatively low.”
Fanelli et al. (2026a) “DISCUSSION”: “Distinct readiness profiles emerged, ranging from countries combining high exposure with strong operational capacity, such as Zambia, Ethiopia and Tanzania, to countries where high importation risk coincides with substantial readiness gaps, including South Sudan, Burundi, and the Central African Republic. South Sudan, the country at highest importation risk, combined intermediate-low emergency preparedness and response with limited healthcare system capacity, raising concerns that imported cases could more readily generate secondary transmission.”
Gashema & Muvunyi (2026) “Importation risk alone does not determine epidemic outcomes. Countries with strong surveillance systems, diagnostic capacity, a trained health-care workforce, and effective infection prevention and control measures can successfully contain imported cases before widespread transmission occurs. Conversely, gaps in surveillance systems and health governance can facilitate epidemic propagation and delay effective response.”
Walekhwa et al. (2026) “Research in Context”: “Enhanced cross-border surveillance under International Health Regulations 2005 and the Africa CDC Public Health Emergency of Continental Security framework is crucial to harmonise detection and response across the DR Congo–Uganda–South Sudan tripoint.”
Bouhentala & Kadir (2026) “Abstract”: “Introduction likelihood was assessed as very low to low for North Africa and very low for the general European population; delayed recognition in routine healthcare was the principal scenario for limited secondary transmission.”
Bouhentala & Kadir (2026) “Abstract”: “Preparedness in North Africa and Europe should prioritise complete exposure histories, rapid isolation, validated diagnostics, protected clinical care, and contact management rather than reliance on border screening.”
Richard et al. (2026) “Results”: “CDC assessed the overall risk posed by the ongoing BVD outbreak to the U.S. population during the next 3 months as low. This assessment was made with moderate confidence, given the data available.”
van Zandvoort et al. (2026) “Conclusion”: “The risk of undetected Ebola virus transmission outside Africa is low. Nearly all confirmed Ebola disease cases reported outside Africa have been linked to known occupational exposures, with reasons for travel specific to outbreak response. We emphasise the role of local, community-based case management and infection prevention and control measures as the most effective strategy for managing outbreak risks both overall and outside the source region.”
van Zandvoort et al. (2026) “Discussion”: “Crucially, most Ebola disease cases reported outside Africa (27 of 28 cases) have been either (i) primary cases in individuals with a known responsive or occupational exposure to an Ebola disease epidemic (24 cases, including 20 healthcare workers, three UN employees and one journalist, among whom 20 were medically evacuated) or (ii) secondary cases in healthcare workers treating an Ebola disease patient outside Africa (3 cases). There was only one reported confirmed case outside Africa in a traveller with no responsive or occupational exposure.”
Verheyden and Mudogo (2026) “Abstract”: “We modelled the discrete-time hazard of a first reported confirmed case across 106 health zones in four provinces affected by the 2026 Bundibugyo virus disease outbreak (47 affected, 59 at risk, 26 July 2026), comparing four connectivity specifications - none, road-distance, a gravity score, and an incidence-weighted force-of-infection (FOI) term - fitted within an identical Bayesian hierarchical hazard architecture.”
Verheyden and Mudogo (2026) “Abstract”: “FOI had the highest top-10 hit rate (42.6%), approaching conventional significance against road-distance and no-connectivity comparators. On AUC-PR, a model with no connectivity term performed as well as or better than any connectivity specification (0.437 vs. 0.409 for FOI), a discrepancy we report rather than omit.”
Verheyden and Mudogo (2026) “3 Results”: “The top-ranked zone, Rethy (Ituri), had a posterior median daily hazard of 0.095 (95% CrI [0.018, 0.295]), corresponding to roughly a 75% chance of reporting a first case within 14 days if current conditions persisted; the 20th-ranked zone’s daily hazard corresponds to roughly 4% over the same window.”
Verheyden and Mudogo (2026) “3 Results”: “On the pre-specified primary metric (top-10 hit rate), FOI was highest (42.6%), followed by OSRM-distance and gravity (both 32.8%), then baseline (29.5%).”
Verheyden and Mudogo (2026) “3 Results”: “On AUC-PR, the secondary metric with the most divergent picture, the baseline model with no connectivity term at all performed as well as or better than every connectivity specification (baseline 0.437 vs. FOI 0.409, gravity 0.399, OSRM-distance 0.239), and FOI’s advantage over baseline on this metric was not distinguishable from zero (−0.027, 95% CI [−0.274, 0.200]).”
Verheyden and Mudogo (2026) “3 Results”: “Across a grid of 8 alternative combinations (φ ∈ {30,60,120} minutes × window ∈ {1,3,7} days), the resulting zone ranking correlated with the primary specification’s ranking at Spearman ρ = 0.90-0.99, with top-10 overlap of 9 or 10 out of 10 zones in every combination tested.”
Verheyden and Mudogo (2026) “1 Introduction”: “This paper develops a discrete-time hazard model in which spatial connectivity is represented by the observed incidence in every currently affected zone, propagated to at-risk zones through a road-network distance-decay kernel, rather than by geometric distance to the nearest affected zone alone. We refer to this as an incidence-weighted spatial force-of-infection (FOI) hazard model.”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “Daily case data from the INRB-UMIE BDBV2026-Data repository (Mbulayi et al., 2026). Static covariates: WorldPop population estimates; OpenStreetMap/HOT health-facility points; Complex Crisis Vulnerability Index; province-level ACLED conflict events (Raleigh et al., 2010). Road-network travel times from a national OSRM graph.”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “CDR/mobility data were not used, as DRC is not among the countries for which this is available (Wardle et al., 2023).”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “The FOI kernel’s decay scale (φ, fixed at 60 minutes in the primary specification) and smoothing window (3 days) were not tuned against performance; we instead report ranking stability across a grid of plausible alternatives, refitting the full model at each combination and comparing the resulting zone ranking to the primary specification via Spearman rank correlation and top-10 overlap: φ ∈ {30, 60, 120} minutes × window ∈ {1, 3, 7} days (8 combinations in addition to the primary specification).”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “Four specifications of xz(t)'s connectivity term were compared, all embedded in the identical model described in Section 2.3, differing only in this one covariate: 1. Baseline: no connectivity term (four static covariates only). 2. Road-distance: log(1 + travel time to the nearest already-affected zone), the specification used in an earlier version of this analysis. 3. Gravity: a population-weighted score summed over all affected zones: - (iv) FOI (primary specification): incidence-weighted, kernel-summed force of infection,.”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “Fitting all four within the identical architecture, rather than comparing a fitted model against externally-computed rankings, isolates what each connectivity term contributes beyond the static covariates and beyond each other, and was added specifically in response to reviewer concern that an earlier version compared a fitted model to uncalibrated external scores.”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “Eight weekly origins, 21 May-9 July 2026, each refit using only data available through that origin, scored against zones reporting a first case within the following 14 days (Tashman, 2000). We designate top-10 hit rate - the proportion of true next-invading zones ranked in the model’s top 10 at that origin - as the primary evaluation metric, specified before examining comparative results across specifications, because the operational decision this model is built to support is which small number of zones warrant prioritised attention, not discrimination across the full 59-zone risk set.”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “We used a cluster (block) bootstrap resampling whole origins with replacement (10,000 resamples), for each replicate pooling the zone-level rows (or origin-level AUC-PR values) belonging to the resampled origin set and recomputing each metric as in the point estimate.”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “We report two further checks: leave-one-origin-out (recomputing pooled metrics excluding each origin in turn, to assess whether any single origin drives the result), and a non-overlapping-origin subset (4 origins spaced exactly 14 days apart: 21 May, 4 June, 18 June, 2 July), which removes horizon overlap entirely at the cost of halving the usable origins and events (61 to 35).”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “A secondary, exploratory analysis - not a second validated model of comparable standing to the hazard model above - examined near-term case growth for the 47 zones already affected, using a hierarchical negative-binomial growth-rate model (an initial Poisson specification was found miscalibrated on rolling-origin backtesting and corrected).”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “We summarise the headline finding here (Section 3.5) and do not present a combined invasion-plus-growth ranking as a validated decision tool in the main paper, since that combined ranking has not itself been backtested.”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “with kernel K(z,z’) = exp(−d(z,z’)/φ), φ = 60 minutes (default), and Cz’(t) the 3-day trailing mean of new confirmed cases in zone z’ through day t − 2 (Section 2.4).”
Verheyden and Mudogo (2026) “3 Results”: “The FOI kernel’s decay scale and smoothing window were not tuned against performance. Across a grid of 8 alternative combinations (φ ∈ {30,60,120} minutes × window ∈ {1,3,7} days), the resulting zone ranking correlated with the primary specification’s ranking at Spearman ρ = 0.90-0.99, with top-10 overlap of 9 or 10 out of 10 zones in every combination tested.”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “Same-day leakage - using zone z’s incidence recorded on day t to predict zone z’s outcome on day t - is addressed directly: the FOI covariate (Section 2.5) uses only incidence through day t−2, never day t or t−1.”
Verheyden and Mudogo (2026) “3 Results”: “This is smaller than an earlier, same-day (non-lagged) specification’s estimate of +0.610 [0.43, 0.79]; fixing same-day information leakage (Section 2.4) reduced the coefficient’s magnitude by roughly 40%, confirming the leakage had inflated the apparent effect, though the corrected estimate still excludes zero.”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “The outcome modelled is a zone’s first reported confirmed case, denoted Tz, with yz(t) = 1 on the day this occurs. We use this precise language deliberately rather than ‘invasion’: first confirmation reflects viral introduction, local transmission, detection, testing access, reporting capacity, and retrospective case reclassification jointly, and the model cannot separate these.”
Verheyden and Mudogo (2026) “3 Results”: “Health-facility density (β = +0.486, [0.245, 0.734]) and population (β = +0.400, [0.087, 0.720]) were also associated with hazard at the 95% credible level; socioeconomic deprivation (+0.326, [−0.074, 0.754]) and province-level conflict exposure (+0.156, [−0.640, 0.900]) were not.”
Verheyden and Mudogo (2026) “4 Discussion”: “Conflict exposure is measured only at province level across four provinces, alongside a province random effect estimated from the same four groups; this covariate’s estimate should be read as exploratory.”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “Data-vintage leakage - whether the case counts available to us for a historical date t already reflect corrections made after t, since we hold only the final, most recently corrected version of the dataset rather than dated historical snapshots - cannot be ruled out with the data available to us. We flag this explicitly rather than assume it away, and for this reason describe the rolling-origin evaluation throughout as pseudo-prospective: a reconstruction of what a real-time analysis would have produced, run retrospectively on the best data now available, not a true contemporaneous test.”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “Linear predictor: with a piecewise-constant weekly baseline evolving as a random walk: a non-centred province random effect (Betancourt and Girolami, 2015): weakly informative priors: and the discrete-time survival log-likelihood, summed over zones and at-risk days:.”
Verheyden and Mudogo (2026) “1 Introduction”: “Second, because historical snapshots of the surveillance dataset at each rolling-origin date were not available to us, we cannot rule out that some retrospective data revision (case reclassification, backfilled reports) is reflected in what our evaluation treats as contemporaneously known information. We therefore describe the rolling-origin evaluation as pseudo-prospective throughout, reserving the term prospective for the genuinely pre-registered future verification described in Section 2.10.”
Verheyden and Mudogo (2026) “1 Introduction”: “None of these efforts provides a validated, prospectively evaluated model of zone-level invasion risk specifically, and existing approaches that do address spatial spread typically rely on mobile-phone call detail record (CDR) data, which a systematic review found available in only a small number of African countries, not including the DRC (Wardle et al., 2023).”
Verheyden and Mudogo (2026) “4 Discussion”: “The top-10-vs-OSRM-distance comparison reaches only the boundary of conventional significance (CI lower bound 0.000); we would not describe this as a robust result on its own and rely on the convergent evidence across the primary metric, the sensitivity grid, and the leave-one-origin-out and non-overlapping-origin checks collectively, rather than on any single comparison.”
Verheyden and Mudogo (2026) “3 Results”: “On AUC-PR, the secondary metric with the most divergent picture, the baseline model with no connectivity term at all performed as well as or better than every connectivity specification (baseline 0.437 vs. FOI 0.409, gravity 0.399, OSRM-distance 0.239), and FOI’s advantage over baseline on this metric was not distinguishable from zero (−0.027, 95% CI [−0.274, 0.200]). We report this plainly rather than selectively: a global discrimination metric like AUC-PR rewards a model for correctly ranking the bulk of zones that will not invade soon, which the static covariates alone (population, facility density, deprivation) appear to do reasonably well without any connectivity information; the connectivity terms’ distinguishable contribution is specifically to sharpening the top of the ranking, which is what the primary metric measures and what the operational use case (which few zones get attention first) requires.”
Verheyden and Mudogo (2026) “4 Discussion”: “The growth-rate extension (Section 3.5) has not been backtested as a combined ranking with the hazard model, and we do not present one for that reason.”
Verheyden and Mudogo (2026) “4 Discussion”: “Fixed choices not evaluated here include the OSRM travel-time transformation and the province-level (rather than zone-level) conflict aggregation.”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “Daily case data from the INRB-UMIE BDBV2026-Data repository (Mbulayi et al., 2026).”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “Retrospective, pseudo-prospective observational study of health-zone-level case emergence during the 2026 BDBV outbreak, 14 May-26 July 2026 (74 days).”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “This construction yields 5,727 zone-day observations, 47 events.”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “Static covariates: WorldPop population estimates; OpenStreetMap/HOT health-facility points; Complex Crisis Vulnerability Index; province-level ACLED conflict events (Raleigh et al., 2010).”
Verheyden and Mudogo (2026) “2 Materials and Methods”: “Road-network travel times from a national OSRM graph.”
Verheyden and Mudogo (2026) “4 Discussion”: “An independent Flowminder-based mobility analysis found the outbreak’s three epicentre zones among the top 5% of DRC health zones nationally on mobility intensity (Bangelesa et al., 2026, as summarised in Walekhwa et al., 2026), using data and methodology with no overlap with ours.”
Epistorm (2026) “Executive Summary”: “No transmission model is used at this stage; the analysis describes where any exported case is most likely to be detected, conditional on at least one export occurring.”
Epistorm (2026) “Key Findings”: “**Proximity spillover concentrates in western Uganda and Juba. ** Across the neighbouring countries, 99.2 % of the city-level RR mass sits in five cities: Kasese (UGA, 56.3 %), Pakuba (UGA, 25.4 %), Arua (UGA, 12.8 %), Juba (SSD, 3.1 %), and Entebbe (UGA, 1.5 %), with Kigali (RWA), Dar Es Salaam (TZA), Bangui (CAF), and Bujumbura (BDI) capturing the remaining thin margin (each below 0.05 %).”
Epistorm (2026) “Key Findings”: “** With only Uganda excluded and the remainder renormalised, South Sudan takes 80.1 % of the tail (Juba alone 79.6 %).”
Epistorm (2026) “Neighbouring-Country Cities”: “Across DRC’s nine neighbouring countries, the mobility model concentrates 99.2 % of the non-DRC relative risk mass in a small number of cities on the eastern side of the country. Five cities (Kasese in Uganda’s Western Region, Pakuba in Northern Region, Arua in West Nile Region, Entebbe near Kampala; Juba in South Sudan’s Central Equatoria State) together account for 99.2 % of the neighbour total.”
Epistorm (2026) “Neighbouring-Country Cities”: “Uganda alone accounts for 96.1 % of the non-DRC mass and is the sole country removed from the tail in Sections 4 and 5.”
Epistorm (2026) “Regional Distribution · International Tail”: “With DRC and Uganda removed and the remainder renormalised to sum to one, the tail is dominated by South Sudan: Juba alone carries 79.6 %, and Rumbek adds a further 0.5 %. This reflects the strong overland connectivity from north-eastern DRC into South Sudan captured by the mobility model.”
Epistorm (2026) “Regional Distribution · International Tail”: “Africa carries 89.4 % of the tail (South Sudan alone 80.1 %; then Kenya 2.8 %, Tanzania 1.1 %, Rwanda 0.8 %, South Africa 0.8 %, Ethiopia 0.7 %). The Middle East accounts for 4.9 % (UAE 3.2 %, Saudi Arabia 0.9 %, Qatar 0.3 %), Europe for 3.0 % (United Kingdom 1.0 %, Germany 0.3 %, Belgium 0.3 %), Asia for 2.0 % (India 0.9 %, China 0.7 %), the Americas for 0.7 % (United States 0.5 %, Canada 0.2 %), and the “Other” residual sits at 0.1 %.”
Epistorm (2026) “Executive Summary”: “** The absolute probability of any single international export remains small.”
Epistorm (2026) “Executive Summary”: “They represent the share of international export probability that would land in each destination if an international export were to occur. They do not represent the absolute probability that an export will occur.”
Epistorm (2026) “Methods Overview”: “Global air travel patterns are derived from the International Air Transport Association (IATA) and the Official Airline Guide (OAG), providing passenger-level origin-destination flows between international airports. These data are complemented by short-scale commuting patterns capturing daily movements between adjacent subpopulations, representing the local spread of disease through routine human activity within and across health zones. The modeling approach follows the GLEAM (Global Epidemic and Mobility) computational framework [4,5].”
Epistorm (2026) “Methods Overview”: “For each potential destination Y, the model estimates the probability P(Y) that an infected individual originating in the affected area travels to Y, conditional on at least one exported case occurring. The output is a relative risk distribution across all candidate destinations, normalized so that values represent the share of importation probability assigned to each location.”
Epistorm (2026) “Methods Overview”: “The first (Section 3) reports the city-level RR across DRC’s neighbouring countries (before renormalisation), showing that Uganda alone accounts for 96.1 % of the non-DRC mass.”
Epistorm (2026) “Methods Overview”: “The second (Sections 4 and 5) removes only Uganda and renormalises the remaining mass over 117 international destinations reachable by air.”
Epistorm (2026) “Executive Summary”: “The framework is unchanged from Reports #1 to #4: air-travel and short-scale commuting flows are combined into a mobility-only relative importation risk (RR), evaluated over a two-week horizon.”
Epistorm (2026) “Limitations &; Assumptions”: “This report uses the mobility framework only. No transmission-dynamics model is applied, and the RR values should not be read as forecasts of future case counts at any destination.”
Epistorm (2026) “Methods Overview”: “The mobility model does not simulate country-level border-control interventions such as entry screening, restrictions on travellers from the affected area, or air-service suspensions.”
Epistorm (2026) “Limitations &; Assumptions”: “The model does not include country-level border-control interventions such as entry screening, restrictions on travellers from the affected area, or air-service suspensions.”
Epistorm (2026) “Methods Overview”: “Readers should treat the RR values here as the mobility-only baseline.”
Epistorm (2026) “Limitations &; Assumptions”: “The RR values here should be interpreted as the mobility-only baseline.”
Epistorm (2026) “Limitations &; Assumptions”: “The incubation period of Bundibugyo virus (2-21 days; average ~10 days) constrains the window within which an exported case could reasonably travel while infectious or pre-symptomatic.”
Epistorm (2026) “Limitations &; Assumptions”: “Case importations are modelled as statistically independent events.”
Epistorm (2026) “Limitations &; Assumptions”: “The mobility model does not incorporate sociodemographic attributes of travellers (age, economic status, occupation, or pre-existing medical conditions), any of which may modulate both exposure risk at origin and care-seeking behaviour at destination. Travel probability within a catchment area is treated as independent of these attributes and of specific location within the catchment.”
Epistorm (2026) “Limitations &; Assumptions”: “These estimates apply to traffic from the general population.”
Epistorm (2026) “Limitations &; Assumptions”: “The importation risk associated with repatriation flights, responder evacuations, or other ad-hoc operational movements is not part of this analysis.”
Epistorm (2026) “Limitations &; Assumptions”: “Mobility data may not fully capture informal cross-border movement, which is substantial within the immediate cross-border region but is not the focus of the international-tail analysis in Sections 4 and 5.”
Epistorm (2026) “Limitations &; Assumptions”: “The model does not predict downstream transmission chains following an importation event: risk estimates reflect the probability of a single importation and do not account for the probability of sustained local transmission in the receiving location.”
Epistorm (2026) “Limitations &; Assumptions”: “Real-world events involving multiple related cases (for example, a family cluster travelling together) are counted as a single importation event. To the extent that such clusters are common, the model will under-count the number of distinct exposure events while correctly counting the number of distinct geographic seedings.”
Epistorm (2026) “Limitations &; Assumptions”: “The mobility model does not incorporate sociodemographic attributes of travellers (age, economic status, occupation, or pre-existing medical conditions), any of which may modulate both exposure risk at origin and care-seeking behaviour at destination.”
Epistorm (2026) “Executive Summary”: “This update refreshes the international-dissemination assessment using the 23 July 2026 DRC data.”
Epistorm (2026) “Methods Overview”: “Global air travel patterns are derived from the International Air Transport Association (IATA) and the Official Airline Guide (OAG), providing passenger-level origin-destination flows between international airports.”
Epistorm (2026) “Methods Overview”: “These data are complemented by short-scale commuting patterns capturing daily movements between adjacent subpopulations, representing the local spread of disease through routine human activity within and across health zones.”
Epistorm (2026) “Situation at a glance”: “Incubation period 2-21 days · average ~10 days (from 2007 outbreak).”
Epistorm (2026) “Situation at a glance”: “Pathogen Bundibugyo virus, second Ebola species; first isolated 2007, Uganda; confirmed CFR ~14% (DRC/UGA combined).”
Bouhentala & Kadir (2026) “Abstract”: “Risk was assessed across introduction likelihood, conditional onward-transmission likelihood, impact, and confidence.”
Bouhentala & Kadir (2026) “3. Results”: “As of 15 July 2026, the DRC had reported 2,124 laboratory-confirmed cases, 828 deaths among confirmed cases, 390 reported recoveries, and 725 patients hospitalised in isolation. Confirmed cases had been reported from 46 of 140 health zones across five provinces.”
Bouhentala & Kadir (2026) “3. Results”: “Excluding the 29 June – 1 July interval, the aggregate rate was 35.9 per day during 2–29 June (970 notifications over 27 days; exact counting interval 33.7–38.3) and 47.4 per day during 1–15 July (664 over 14 days; 43.9–51.2). The July-to-June notification-rate ratio was 1.32 (counting-model 95% interval 1.20–1.46).”
Bouhentala & Kadir (2026) “3. Results”: “ECDC estimated approximately one importation per 23,000–24,000 travellers from the principal outbreak region, with a 90% uncertainty interval of one per 13,000–54,000. Under a hypothetical scenario of 100 travellers during 11–25 June, ECDC estimated a 0.45% probability of at least one importation (90% uncertainty interval 0.20%–0.85%).”
Bouhentala & Kadir (2026) “2. Methods”: “This was a rapid public-health analysis of publicly available aggregate surveillance data and official risk assessments. The principal sources were WHO Disease Outbreak News, WHO/IHR statements and technical guidance, ECDC surveillance and modelling reports, WHO regional offices, national ministry-of-health dashboards and updates, and peer-reviewed primary studies for historical BDBV outbreaks, viral persistence, and candidate countermeasures.”
Bouhentala & Kadir (2026) “2. Methods”: “Airline sources were used only to establish the existence of plausible routes and not to estimate passenger volumes.”
Bouhentala & Kadir (2026) “2. Methods”: “Cumulative confirmed DRC counts were indexed by reporting date rather than symptom-onset date. Interval-specific average notification rates were calculated as the change in cumulative confirmed cases divided by the number of days between reports. Exact 95% Poisson counting intervals were calculated using the Garwood method.”
Bouhentala & Kadir (2026) “2. Methods”: “The notification-rate ratio comparing 1–15 July with 2–29 June was calculated as (C₁/t₁)/(C₀/t₀). The 95% interval was estimated on the log scale using SE[log(RR)] = √(1/C₁ + 1/C₀).”
Bouhentala & Kadir (2026) “2. Methods”: “No reproduction number was estimated because onset-date line-list data were unavailable.”
Bouhentala & Kadir (2026) “2. Methods”: “Risk was separated into four dimensions: introduction likelihood, conditional onward-transmission likelihood after an importation, impact if detection was delayed, and confidence in the judgement. Categories were comparative reference classes rather than calibrated probabilities. Boundary ratings such as ‘very low to low’ were retained when the evidence did not support a more precise classification.”
Bouhentala & Kadir (2026) “2. Methods”: “The ratings were calibrated against WHO’s 6 June assessment, which classified risk as very high in the DRC, high in Uganda and bordering countries, low in the remainder of the WHO African Region, and low globally.”
Bouhentala & Kadir (2026) “2. Methods”: “These intervals describe counting variation only and do not incorporate systematic uncertainty from backlogs, under-ascertainment, changing testing, or reporting delays.”
Bouhentala & Kadir (2026) “3. Results”: “This increase cannot be interpreted as a direct measure of biological acceleration. WHO noted that expanded surveillance, testing, and diagnostic capacity contributed to rising reported counts, and newly reported cases could include backlogs.”
Bouhentala & Kadir (2026) “2. Methods”: “Risk was separated into four dimensions: introduction likelihood, conditional onward-transmission likelihood after an importation, impact if detection was delayed, and confidence in the judgement. Categories were comparative reference classes rather than calibrated probabilities.”
Bouhentala & Kadir (2026) “3. Results”: “Passenger-volume and confidential readiness data were unavailable.”
Bouhentala & Kadir (2026) “4. Discussion”: “Conversely, a recognised symptomatic case can usually be contained because transmission requires direct contact with blood or other body fluids, contaminated materials, or the body of a deceased case rather than ordinary casual proximity.”
Bouhentala & Kadir (2026) “4. Discussion”: “An incubating traveller can cross a border while asymptomatic because people are not considered infectious before symptom onset and the incubation period can extend to 21 days. Temperature screening may detect some symptomatic travellers but cannot exclude infection during incubation.”
Bouhentala & Kadir (2026) “3. Results”: “A final departure airport may conceal earlier travel to eastern DRC; triage therefore requires a complete 21-day itinerary and exposure history.”
Bouhentala & Kadir (2026) “2. Methods”: “Arithmetic cumulative doubling times were treated as descriptive properties of the cumulative curve and not as evidence of changes in transmission.”
Bouhentala & Kadir (2026) “4. Discussion”: “Passenger volumes, traveller occupations, deployment rosters, medevac activity, and country-specific laboratory and referral readiness were incomplete. Country ratings were therefore comparative judgements rather than calibrated probabilities.”
Bouhentala & Kadir (2026) “4. Discussion”: “Nevertheless, notification rates remain composite measures of infection, care seeking, alert investigation, specimen transport, laboratory capacity, retrospective death investigation, and reporting. The exact Poisson intervals are therefore deliberately described as counting-model intervals rather than complete epidemiological uncertainty intervals.”
Bouhentala & Kadir (2026) “3. Results”: “This rise is compatible with maturation of outcomes among previously active cases, retrospective confirmation of deaths, delayed presentation, preferential detection of severe disease, delayed recovery reporting, and changes in testing or death investigation. It should not be interpreted as a time-resolved measure of clinical virulence.”
Bouhentala & Kadir (2026) “3. Results”: “The published status totals did not fully reconcile: 828 deaths, 390 recoveries, and 725 hospitalised patients summed to 1,943, leaving 181 of 2,124 confirmed cases outside those categories. Public reports did not define the status of these cases. Potential explanations include pending admission or outcome reconciliation, transfers, and reporting lags, but no category could be assigned without line-list data.”
Bouhentala & Kadir (2026) “4. Discussion”: “The analysis was time-stamped and may be superseded by subsequent official reports.”
Bouhentala & Kadir (2026) “Abstract”: “** Public surveillance reports from the World Health Organization (WHO), European Centre for Disease Prevention and Control (ECDC), Africa CDC, national ministries of health, and peer-reviewed sources were synthesised through 15–17 July 2026.”
Bouhentala & Kadir (2026) “2. Methods”: “The main DRC trajectory used laboratory-confirmed cases and deaths among confirmed cases. Suspected, probable, and confirmed categories were not summed across reports because individuals and deaths can be reclassified as investigations progress.”
Bouhentala & Kadir (2026) “3. Results”: “As of 17 July, Uganda’s official dashboard reported 20 confirmed cases, two confirmed deaths, 18 recoveries, and no current admissions.”
Bouhentala & Kadir (2026) “3. Results”: “WHO’s jurisdictional accounting on 17 July comprised 2,145 confirmed cases globally: 2,124 in the DRC, 20 in Uganda, and one in France, with 830 confirmed-case deaths.”
Bouhentala & Kadir (2026) “2. Methods”: “The principal sources were WHO Disease Outbreak News, WHO/IHR statements and technical guidance, ECDC surveillance and modelling reports, WHO regional offices, national ministry-of-health dashboards and updates, and peer-reviewed primary studies for historical BDBV outbreaks, viral persistence, and candidate countermeasures.”
Bouhentala & Kadir (2026) “3. Results”: “ECDC estimated approximately one importation per 23,000–24,000 travellers from the principal outbreak region, with a 90% uncertainty interval of one per 13,000–54,000.”
Bouhentala & Kadir (2026) “3. Results”: “These were separately generated Monte Carlo summaries and should not be forced into exact reciprocal equivalence.”
Fanelli et al. (2026a) “ABSTRACT”: “We developed an integrated spatial framework combining high-resolution epidemic and population data, air and land mobility, geographical accessibility, conflict-adjusted travel times to estimate the risk of Ebola importation across African countries. We contextualized importation risk using different national readiness indicators.”
Fanelli et al. (2026a) “ABSTRACT”: “Importation risk was highly concentrated geographically, with neighbouring countries accounting for 85% of the estimated continental risk. However, high-risk destinations extended beyond the immediate neighbours, whereas some neighbouring countries remained at low risk, reflecting the complementary roles of land and air mobility in shaping regional dissemination. South Sudan, Rwanda, Kenya, Tanzania, Zambia, Ethiopia, Burundi, Angola, South Africa, the Central African Republic, and Nigeria were estimated at high risk, but differed markedly in healthcare system capacity and emergency preparedness and response. Readiness gaps were largest in South Sudan, Burundi, and the Central African Republic.”
Fanelli et al. (2026a) “RESULTS”: “The 11 countries in the high-risk quartile — South Sudan, Rwanda, Kenya, Zambia, Ethiopia, Tanzania, Burundi, Angola, South Africa, Central African Republic, and Nigeria — accounted for 93% of the total estimated importation risk, and formed a largely contiguous regional belt surrounding the affected area, with the exception of Ethiopia, South Africa, and Nigeria, which were geographically more distant (at border distance 2, 3, and 3 from the outbreak source, respectively).”
Fanelli et al. (2026a) “RESULTS”: “Neighboring countries alone accounted for 85% of the total estimated risk, while countries located two border crossings away contributed an additional 9%, highlighting the strong spatial concentration of potential spread around the outbreak source (Fig. 2f).”
Fanelli et al. (2026a) “RESULTS”: “Ethiopia, South Africa, and Nigeria were the only non-neighbouring countries classified as high risk overall, and each ranked substantially higher when considering air importation risk than land importation risk: Ethiopia ranked first for air importation risk but fifth for land importation risk, while South Africa ranked third and ninth, respectively, and Nigeria seventh and eleventh.”
Fanelli et al. (2026a) “RESULTS”: “Epidemic amplification in Nairobi and Lusaka produced the largest increase in continental importation (4-fold increase), and especially in southern Africa (up to 15-fold). Amplification in Kampala and Kigali produced a moderate increase in importation risk across the continent (2.5-fold and 2.8-fold, respectively), whereas expansion to Kinshasa, Bujumbura, or Juba produced comparatively limited continental effects.”
Fanelli et al. (2026a) “INTRODUCTION”: “We developed an integrated analytical framework to estimate the risk of Ebola Bundibugyo dissemination in Africa in relation to national readiness, by combining epidemiological and high-resolution spatial population data, commercial air transportation, land mobility, geographical accessibility, conflict-adjusted travel-times, and different readiness scores.”
Fanelli et al. (2026a) “METHODS”: “The importation risk for each African country was estimated separately for air and land mobility, as the probability that an infected traveller from the affected areas would reach that country. We assumed that Ebola infected cases could travel only in their latent phase, as symptomatic patients would be expected to either remain in the affected country for clinical management or, if transferred internationally, travel under medically supervised and controlled conditions. Therefore, for land mobility, travel times were explicitly incorporated to estimate the destination reached before the onset of symptoms. For air travel, journey times were considered negligible relative to the incubation period.”
Fanelli et al. (2026a) “METHODS”: “Risks were weighted by the cumulative attack rate in each affected administrative unit. Air and land importation risks were then combined to obtain an overall estimate of relative importation risk for each destination country.”
Fanelli et al. (2026a) “METHODS”: “Air mobility was derived from the International Air Transport Association (IATA) data on origin–destination passenger flows between any pair of commercial airports and accounting for connections at intermediate airports (Fig. 1c).”
Fanelli et al. (2026a) “METHODS”: “For air travel, it was assigned using weights proportional to population size and decreasing with the distance to each airport of the country.”
Fanelli et al. (2026a) “METHODS”: “Land mobility was then obtained as residual mobility by subtracting air mobility from the Global Transnational Mobility Dataset 2.0 (GTMD2), which provides estimates of overall population movements between countries (Fig. 1d).”
Fanelli et al. (2026a) “METHODS”: “To characterize spatial accessibility from the outbreak area and the potential for land-based spread within the incubation period, we computed travel-time surfaces using a global motorized-travel friction surface map integrating road networks, land cover, rivers, topography, and transport infrastructure. Travel times were estimated from each affected health district (DRC) and ADM3 units (Uganda) to all destination countries in Africa. As armed conflict can substantially alter travel time, our estimates were adjusted for conflict-related disruptions using the most recent conflict data at ADM2 level obtained from the Armed Conflict Location & Event Data Project (ACLED), and calibrated against Google Maps driving-time estimates.”
Fanelli et al. (2026a) “METHODS”: “For land travel, the share of the population in each administrative unit travelling to each destination country was estimated through a gravity model calibrated on observed land mobility patterns.”
Fanelli et al. (2026a) “DISCUSSION”: “Although uncertainty remains, sensitivity analyses reducing land mobility by 66% and 90% produced only limited changes in country rankings, supporting the robustness of our findings. Second, land-mediated importation risk was estimated assuming an average travel duration of 8h per day, and analyses were restricted to contiguous Africa because comparable data on maritime mobility are not available. Alternative travel durations produced no changes in the estimated geography of risk.”
Fanelli et al. (2026a) “METHODS”: “National epidemic readiness was assessed using several complementary frameworks, including the WHO State Parties Self-Assessment Annual Reporting (SPAR, 2025), the Global Health Security Index (GHS, 2021), the Infectious Disease Vulnerability Index (IDVI, 2016), and the Epidemic Risk Index (INFORM-WHO, 2020). From each framework, we extracted indicators describing Healthcare system capacity and Emergency preparedness and response.”
Fanelli et al. (2026a) “METHODS”: “Given its complete coverage of African countries, recent update, and direct relevance to the current WHO Framework for Health Emergency Preparedness and Response Capabilities for national public health agencies, SPAR was selected as the primary epidemic readiness metric for the main analysis (Fig. 1fg).”
Fanelli et al. (2026a) “METHODS”: “Corresponding GHS indicators, complementary to SPAR indicators, were used in sensitivity analyses.”
Fanelli et al. (2026a) “METHODS”: “Amplification scenarios were designed to assess the potential impact of geographical expansion of the epidemic beyond the currently affected area into highly connected urban centers. Tested locations included the capital cities of the two affected countries, Kinshasa (DRC) and Kampala (Uganda), and the capitals of neighboring countries scoring highest in importation risk: Juba (South Sudan), Kigali (Rwanda), Bujumbura (Burundi), Nairobi (Kenya), and Lusaka (Zambia).”
Fanelli et al. (2026a) “METHODS”: “To account for geographically heterogeneous reporting rates, we used the proportion of alerts investigated among reported alerts in each DRC province, averaged over the two weeks preceding 5 July 2026, relative to 100% reporting in Uganda. We explored alternative values in the sensitivity analysis.”
Fanelli et al. (2026a) “METHODS”: “We assumed that Ebola infected cases could travel only in their latent phase, as symptomatic patients would be expected to either remain in the affected country for clinical management or, if transferred internationally, travel under medically supervised and controlled conditions.”
Fanelli et al. (2026a) “DISCUSSION”: “We assumed that infected individuals travelled only during the latent phase, consistent with the rapid onset of symptoms and progressive clinical deterioration characteristic of Ebola virus disease. However, some individuals with early or mild symptoms may still travel before seeking care, particularly over shorter distances, potentially increasing importation risk to more distant destinations.”
Fanelli et al. (2026a) “DISCUSSION”: “Similarly, geographically heterogeneous under-ascertainment is difficult to quantify. We therefore used the proportion of investigated alerts as a proxy for reporting rates by health district, and found the results to be robust to alternative assumptions.”
Fanelli et al. (2026a) “DISCUSSION”: “Second, land-mediated importation risk was estimated assuming an average travel duration of 8h per day, and analyses were restricted to contiguous Africa because comparable data on maritime mobility are not available. Alternative travel durations produced no changes in the estimated geography of risk.”
Fanelli et al. (2026a) “METHODS”: “Border restrictions and closures related to the current outbreak were not considered, because the implemented measures were partial, temporary and largely limited to official points of entry. Also, available data on cross-country mobility suggested no meaningful reduction in cross-border movement occurred during such restrictions.”
Fanelli et al. (2026a) “METHODS”: “Risks were weighted by the cumulative attack rate in each affected administrative unit.”
Fanelli et al. (2026a) “DISCUSSION”: “First, reliable data on cross-border land mobility in Africa remain scarce. We therefore estimated land mobility from the best available continental dataset, combining multiple mobility sources and deriving land movements as the residual after discounting commercial air travel.”
Fanelli et al. (2026a) “DISCUSSION”: “Although uncertainty remains, sensitivity analyses reducing land mobility by 66% and 90% produced only limited changes in country rankings, supporting the robustness of our findings.”
Fanelli et al. (2026a) “DISCUSSION”: “Second, land-mediated importation risk was estimated assuming an average travel duration of 8h per day, and analyses were restricted to contiguous Africa because comparable data on maritime mobility are not available.”
Fanelli et al. (2026a) “DISCUSSION”: “Finally, we did not explicitly model behavioural adaptations or the impact of border control measures. While some border restrictions were implemented during the current outbreak, independent mobility data suggested no measurable change in cross-border movements. Moreover, evidence from previous Ebola outbreaks highlights that travel restrictions have limited impact on spatial dissemination while potentially hampering response activities.”
Fanelli et al. (2026a) “DISCUSSION”: “At the same time, recent outbreak experience demonstrates that operational preparedness is not solely determined by structural readiness indicators.”
Fanelli et al. (2026a) “METHODS”: “Cumulative confirmed cases were obtained from the Institut National de Santé Publique (INSP) of the DRC in the daily situation report number 51 published on 5 July 2026, and by the Ministry of Health of Uganda on the update of the same date (Fig. 1a).”
Fanelli et al. (2026a) “METHODS”: “Population data were obtained from the 2024 health-zone population projections produced by the DRC Information Management Working Group and disseminated by the United Nations Office for the Coordination of Humanitarian Affairs (OCHA) through the Humanitarian Data Exchange Platform.”
Fanelli et al. (2026a) “METHODS”: “For Uganda, population estimates at administrative levels 0–3 were obtained from the United Nations Population Fund (UNFPA), based on Uganda Bureau of Statistics data.”
Fanelli et al. (2026a) “METHODS”: “As armed conflict can substantially alter travel time, our estimates were adjusted for conflict-related disruptions using the most recent conflict data at ADM2 level obtained from the Armed Conflict Location & Event Data Project (ACLED), and calibrated against Google Maps driving-time estimates.”
Fanelli et al. (2026a) “METHODS”: “National epidemic readiness was assessed using several complementary frameworks, including the WHO State Parties Self-Assessment Annual Reporting (SPAR, 2025), the Global Health Security Index (GHS, 2021), the Infectious Disease Vulnerability Index (IDVI, 2016), and the Epidemic Risk Index (INFORM-WHO, 2020).”
Fanelli et al. (2026a) “METHODS”: “To account for geographically heterogeneous reporting rates, we used the proportion of alerts investigated among reported alerts in each DRC province, averaged over the two weeks preceding 5 July 2026, relative to 100% reporting in Uganda.”
Gashema & Muvunyi (2026) “A modelling study by Dick Chamla and colleagues, published in The Lancet Infectious Diseases shows how fitted stochastic susceptible, exposed, infectious, recovered and deceased (SEIRD) ensemble modelling can leverage limited data to predict cross-border outbreak spread and inform regional preparedness.”
Gashema & Muvunyi (2026) “Linking outbreak dynamics with spillover risk, Chamla and colleagues move beyond forecasting disease burden toward informing operational preparedness.”
Gashema & Muvunyi (2026) “Stochastic models assume homogeneous population mixing and uniform intervention effectiveness, which potentially overlooking important spatial, health-care, and socioeconomic heterogeneities that shape transmission dynamics.”
Gashema & Muvunyi (2026) “Projections are further constrained by the quality of early surveillance data and approximated mobility patterns, particularly in low or limited resource settings where data gaps are common.”
Gashema & Muvunyi (2026) “Additionally, these models remain restricted in their ability to capture behavioural adaptation and community engagement, including changes in risk perception, health-care seeking behaviour, intervention uptake, and public trust, all of which can substantially influence outbreak trajectories.”
Gashema & Muvunyi (2026) “The estimated 6-week interval between the probable index case and formal outbreak declaration created a window during which transmission chains expanded undetected.”
Gashema & Muvunyi (2026) “The study also demonstrates the limitations of real-time epidemic modelling during rapidly evolving outbreaks. Models developed during unfolding outbreaks inevitably operate under conditions of incomplete information, evolving surveillance systems, and changing response capacities which can affect their ability to accurately predict transmission dynamics. Accordingly, these models are not intended to provide a precise forecast, but rather to identify reasonable transmission trajectories and inform preparedness decisions.”
Gashema & Muvunyi (2026) “Collectively, these limitations underscore the importance of interpreting model outputs as scenario-based estimates that require continuous refinement as more comprehensive epidemiological, mobility, and behavioural data become available.”
Gashema & Muvunyi (2026) “The study also underscores the growing importance of epidemic intelligence systems that integrate epidemiological, laboratory, and mobility data into real-time risk assessments.”
Chamla et al. (2026) “Summary”: “The study aimed to establish a short-term trajectory of the BDBV outbreak and probability of cross-border spillover into countries with elevated risk of importation to guide preparedness priorities. We calibrated a stochastic SEIRD (susceptible, exposed, infectious, recovered, dead) ensemble model to the laboratory-confirmed case series, anchoring on 598 cumulative confirmed cases on 8 June 2026 (day 68) using simulation filtering (calibration window plus or minus 30%; reporting fraction 1.0 for laboratory-confirmed cases).”
Chamla et al. (2026) “Summary”: “A linked daily-hazard spillover model estimated importation probability for Uganda, South Sudan, Rwanda and Burundi over a 12-week horizon.”
Chamla et al. (2026) “Summary”: “Calibrated to the confirmed-case anchor (598 on 8 June 2026; central basic reproduction number [R0] = 1.71), the confirmed-case trajectory is most consistent with the central scenario. Under the central scenario the ensemble projected a median of 990 cumulative confirmed cases by week 12 (24 June 2026; 90% prediction interval [PI] 709 to 1,293) and 174 deaths; the low scenario projected 870 confirmed cases (90% PI 641 to 1,133) and 160 deaths.”
Chamla et al. (2026) “Results”: “Under the central transmissibility scenario (mean accepted R0 = 1.71), the ensemble calibrated to the confirmed-case anchor projected a median of 648 cumulative confirmed cases by week 10 (8 June 2026; 50% prediction interval [PI] 560 to 732), rising to 990 by week 12 (24 June 2026; 50% PI 858 to 1,141 and 90% PI 709 to 1,293), with a projected median of 174 deaths at week 12 (Table 1).”
Chamla et al. (2026) “Results”: “By week 24, the central scenario projected a median of 8,210 cumulative confirmed cases (50% PI 6,636 to 10,287 and 90% PI 5,063 to 13,498) and approximately 1,440 deaths if transmission were merely sustained.”
Chamla et al. (2026) “Results”: “Under the low-transmissibility scenario (mean accepted R0 = 1.42), cumulative confirmed cases reached a median of 870 by week 12 (50% PI 752 to 1,004 and 90% PI 641 to 1,133; 160 deaths) and 3,662 by week 24 (50% PI 2,884 to 4,484 and 90% PI 2,094 to 6,037; 673 deaths; appendix 3 p 10).”
Chamla et al. (2026) “Results”: “Under the high-transmissibility scenario (mean accepted R0 = 2.08), confirmed cases reached a median of 1,364 (50% PI 1,154 to 1,579 and 90% PI 975 to 1,807; 202 deaths) by week 12, rising to 66,420 (50% PI 56,560 to 78,937 and 90% PI 41,718 to 95,881; 10,644 deaths) by week 24 (appendix 3 p 9).”
Chamla et al. (2026) “Results”: “Because the observed confirmed-case trajectory is consistent with the central scenario, the high scenario is not the operative trajectory; it is retained as an upper-bound contingency should control measures lapse.”
Chamla et al. (2026) “Methods”: “We conducted a stochastic modelling study using a discrete-time SEIRD (susceptible, exposed, infectious, recovered, dead) framework, recalibrated to cumulative reported cases in Ituri Province on 18 May 2026 (day 48) and projected forward over a 24-week horizon to 16 September 2026.”
Chamla et al. (2026) “Methods”: “Daily transitions were implemented as binomial draws using standard mass-action incidence (full mathematical specification in appendix 3 p 2). No vaccinated compartment was included, as there is no licensed BDBV-specific vaccine.”
Chamla et al. (2026) “Methods”: “Three transmissibility scenarios (low basic reproduction number [R0] = 1.42; central R0 = 1.71; high R0 = 2.08) spanned published BDBV estimates.”
Chamla et al. (2026) “Methods”: “Response-intensity reductions applied from 15 May 2026 were 20% (low), 25% (central) and 15% (high).”
Chamla et al. (2026) “Methods”: “Calibration was performed by simulation filtering (approximate rejection sampling; not formal Bayesian inference). Replicates were accepted if cumulative laboratory-confirmed cases at day 68 (8 June 2026) fell within plus or minus 30% of 598 (range 419 to 777). We retained 400 calibration-passing replicates per scenario.”
Chamla et al. (2026) “Methods”: “Importation risk to Uganda, South Sudan, Rwanda and Burundi was modelled as a daily Poisson hazard driven by calibrated infectious prevalence, country-specific cross-border mobility, point-of-entry detection sensitivity (from WHO Joint External Evaluation assessments) and travel-while-infectious parameters (Uganda 12%; South Sudan 15%; Rwanda and Burundi 8%). Full equations and parameter values are in appendix 3 (pp 2–3).”
Chamla et al. (2026) “Methods”: “Importation probability = 1 − exp(cumulative 12-week hazard). Probabilities of at least one importation were estimated for Uganda, South Sudan, Rwanda and Burundi.”
Chamla et al. (2026) “Methods”: “Sensitivity analyses examined travel-while-infectious (5 to 25%), reporting completeness (0.60 to 0.90) and catchment size (250,000 to 500,000).”
Chamla et al. (2026) “Methods”: “These distributions were chosen to span the range of published BDBV estimates from the 2007 Uganda and 2012 DR Congo outbreaks.”
Chamla et al. (2026) “Summary”: “Calibrated to the confirmed-case anchor (598 on 8 June 2026; central basic reproduction number [R0] = 1.71), the confirmed-case trajectory is most consistent with the central scenario.”
Chamla et al. (2026) “Methods”: “The latent period was fixed at 9.7 days and the infectious period at 5.0 days, in line with the broader filovirus literature.”
Chamla et al. (2026) “Methods”: “The case-fatality ratio was drawn from a uniform distribution (0.15 to 0.25; appendix 3 pp 3–4), centred on the case-fatality ratio observed among laboratory-confirmed cases in the current outbreak (115 [approximately 19%] of 598 as of 8 June 2026) and consistent with the historical BDBV range.”
Chamla et al. (2026) “Methods”: “Because the analysis is anchored on laboratory-confirmed cases, the reporting fraction was set at 1.0 (laboratory-confirmed cases are, by definition, ascertained); the earlier suspected-case reporting fraction assumption is no longer required.”
Chamla et al. (2026) “Methods”: “The model incorporated a transmission reduction factor representing the combined effects of infection prevention and control measures, community engagement, safe and dignified burial and contact tracing, with reduction factors varying by scenario to reflect differing operational effectiveness from the date of outbreak declaration onward.”
Chamla et al. (2026) “Discussion”: “The response-intensity factor was applied uniformly from 15 May, but real-world response effectiveness varies by place, time, access and community acceptance.”
Chamla et al. (2026) “Methods”: “We modelled transmission within a homogeneously mixing catchment of 350,000 (seven affected health zones, including Ituri and North Kivu). Spatial heterogeneity is not captured; this is a stated limitation.”
Chamla et al. (2026) “Methods”: “Importation risk to Uganda, South Sudan, Rwanda and Burundi was modelled as a daily Poisson hazard driven by calibrated infectious prevalence, country-specific cross-border mobility, point-of-entry detection sensitivity (from WHO Joint External Evaluation assessments) and travel-while-infectious parameters (Uganda 12%; South Sudan 15%; Rwanda and Burundi 8%).”
Chamla et al. (2026) “Methods”: “These parameters were not empirically derived for this outbreak and represent the principal sources of uncertainty in spillover projections.”
Chamla et al. (2026) “Results”: “Varying the travel-while-infectious parameter from 5% to 25% changed Uganda’s importation probability by less than 5 percentage points (now saturating at the upper end of the distribution) but altered South Sudan’s projected importation probability by approximately 20 percentage points (appendix 3 pp 7–8).”
Chamla et al. (2026) “Methods”: “Calibration was performed by simulation filtering (approximate rejection sampling; not formal Bayesian inference).”
Chamla et al. (2026) “Methods”: “The plus or minus 30% tolerance was chosen pragmatically given residual data uncertainty.”
Chamla et al. (2026) “Discussion”: “Homogeneous mixing oversimplifies spatial heterogeneity across health zones; healthcare-worker transmission was not separately modelled; response intensity was applied uniformly; the model is anchored on a single recent confirmed-case datum (598 on 8 June 2026), so the fit is sensitive to that anchor; simulation-filtering is not formal inference (appendix 3 p 6); and informal cross-border mobility estimates are imprecise.”
Chamla et al. (2026) “Discussion”: “The response-intensity factor was applied uniformly from 15 May, but real-world response effectiveness varies by place, time, access and community acceptance. Live mobility data and behavioural adaptation were not incorporated.”
Chamla et al. (2026) “Discussion”: “Surveillance dynamics, particularly the post-declaration case-finding surge, probably contributed to the rapid apparent growth between 15 and 19 May; we addressed this by lowering the reporting fraction and widening the calibration window, but residual confounding between transmission and surveillance intensity remains.”
Chamla et al. (2026) “Discussion”: “Most importantly, the calibration relied on early-phase surveillance counts captured in the first weekly WHO External Situation Report (data as of 18 May); the cumulative suspected-case figure of 528 was only partially resolved into 35 laboratory-confirmed cases at the time of analysis, and the associated death count of 132 reflected surveillance signals across the affected health zones rather than laboratory-confirmed mortality alone (of which there were five). Misclassification, delayed laboratory throughput and ongoing active case finding could each shift the calibration anchor in either direction.”
Chamla et al. (2026) “Discussion”: “These projections require iterative recalibration as new data emerge.”
Chamla et al. (2026) “Discussion”: “The projections presented here should therefore be interpreted as an early situational assessment rather than a definitive forecast and will be updated as verified line-list data become available.”
Chamla et al. (2026) “Discussion”: “Individual-level sex and gender data were not available in the aggregate surveillance reports used for this modelling study; disaggregated analysis by sex or gender was therefore not possible.”
Chamla et al. (2026) “Methods”: “Case data were taken from the WHO AFRO External Situation Reports and the WHO AFRO internal tracker through to 8 June 2026. The laboratory-confirmed case series was used as the primary calibration metric: confirmed cases rose from 33 on 18 May 2026 to 105 on 24 May 2026, and 598 on 8 June 2026.”
Chamla et al. (2026) “Summary”: “Uganda reported seven confirmed cases (three imported; four locally acquired including three healthcare workers; case-fatality ratio 14%).”
Chamla et al. (2026) “Results”: “Cross-border spillover projections (Figure 3 and Table 2) indicated very high importation probability for Uganda (94.2%; expected imports 2.85), where the outbreak is now firmly established: as of 4 June 2026, Uganda reported 19 confirmed cases (including five healthcare-worker infections and two deaths), reflecting sustained importation and onward local transmission since the first imported case.”
Walekhwa et al. (2026) “Abstract”: “** We constructed a data-driven directed weighted mobility network using IOM Displacement Tracking Matrix (DTM) flows collected from 15–24 May 2026 (11,245 observed movements) and the 2024 Uganda census (45.9 million people). A stochastic metapopulation SEIR model, incorporating pre-symptomatic transmission and movement of exposed and infectious individuals, was simulated over 90 days across 135 Ugandan districts and two DRC provinces.”
Walekhwa et al. (2026) “Abstract”: “Under the containment scenario (effective R = 0.35), the model projected a median of 22 cumulative cases (95% CrI: 22–24) and 2 deaths (95% CrI: 2–4) in Kampala over 90 days. All other 134 districts had a median of 0 cases. Non-pharmaceutical interventions at high, moderate, and low compliance produced no statistically significant reduction in cases (22 cases across all scenarios).”
Walekhwa et al. (2026) “3. Results”: “Under the containment scenario (effective R = 0.35), the model projected a median of 22 cumulative cases (95% CrI: 22–24) and 2 deaths (95% CrI: 2–4) over 90 days, all concentrated in Kampala (Table 3). The median total cases ranged from 22 to 22 across compliance scenarios, with 2 deaths, 3 HCW infections, and 0 HCW deaths. The 95% credible intervals overlapped substantially, indicating no statistically significant difference between compliance levels.”
Walekhwa et al. (2026) “3. Results”: “Under the containment scenario, Kampala was the only district with a non-zero median projection, bearing a predicted burden of 22 cases (95% CrI: 22–24) and a 100% probability of a local outbreak (>10 cases). All other 134 districts had a median of 0 predicted cases (upper credible intervals extending to 1 in a small fraction of simulations).”
Walekhwa et al. (2026) “2. Methods”: “The containment scenario (used for district-level predictions) had effective R₀ = 0.35, mobility scale 0.05 (95% reduction), and suppression strength 100. Moderate compliance used R₀ = 0.40, mobility scale 0.08, and suppression strength 50. Low compliance used R₀ = 0.45, mobility scale 0.12, and suppression strength 30.”
Walekhwa et al. (2026) “2. Methods”: “We built both undirected and directed weighted networks from the DTM flow data using the igraph package in R. For the undirected network, we summed reciprocal flows for each unordered pair of locations to obtain a single undirected edge weight. For the directed network, we preserved the original flow directions without collapsing reciprocal edges, allowing computation of in-strength (import risk) and out-strength (export risk) separately. We then added all 135 Ugandan districts and the two DRC provinces as nodes. Districts that did not appear in any flow record remained as isolated nodes with no edges.”
Walekhwa et al. (2026) “2. Methods”: “To impute 12-month movement estimates from the 10-day observed flows, we multiplied the observed weights by 36.5. To assess uncertainty due to the limited 10-day sampling period, we performed bootstrap resampling with 1,000 replicates.”
Walekhwa et al. (2026) “2. Methods”: “We developed a discrete-time, stochastic SEIR model at the node level. Each node maintained five compartments: Susceptible (S), Exposed (E), Infectious (I), Recovered (R), and Dead (D). The latent period was set to 7.5 days and the infectious period to 8.5 days, giving daily progression probabilities σ = 1/7.5 and γ = 1/8.5.”
Walekhwa et al. (2026) “2. Methods”: “Pre-symptomatic transmission was modelled by setting the relative infectiousness of exposed individuals to 0.5 compared to infectious individuals, based on estimates from early EVD outbreaks and the empirical observation that six of the secondary cases in Kampala tested positive while under quarantine.”
Walekhwa et al. (2026) “2. Methods”: “The baseline transmission rate β was derived from the basic reproduction number R₀ = 2.76, calibrated to the early growth of the outbreak (16 cases in 21 days), using β = R₀ / infectious period.”
Walekhwa et al. (2026) “2. Methods”: “The DRC provinces were modelled as explicit nodes with their own SEIR dynamics. We recalibrated the DRC model using actual reported data as of May 25, 2026: 381 confirmed cases, 2,987 exposed contacts, and 64 deaths. Nord-Kivu was initialised with 4,000 exposed and 400 infectious individuals, and Ituri with 500 exposed and 50 infectious, to reproduce these numbers.”
Walekhwa et al. (2026) “Abstract”: “The 7-1-7 agile response was explicitly modelled with dynamic contact tracing coverage (40% → 70% → 85%).”
Walekhwa et al. (2026) “2. Methods”: “To quantify the influence of parameter uncertainty on the total cumulative case count, we performed a global sensitivity analysis using the Sobol method. The first-order sensitivity index Sᵢ measures the fraction of output variance caused by parameter i alone, while the total-order index Tᵢ measures the fraction caused by parameter i and all its interactions with other parameters:.”
Walekhwa et al. (2026) “2. Methods”: “The design used quasi-random Sobol sequences with N = 500 samples, leading to 500 × (11 + 2) = 6,500 model evaluations. For each parameter set, we averaged the output over 3 stochastic replicates to reduce noise. The Sobol indices were then estimated with 200 bootstrap replicates to obtain 95% confidence intervals.”
Walekhwa et al. (2026) “2. Methods”: “We made the following key assumptions: The DTM flow data (10-day period) are representative of average daily movement patterns after scaling by 36.5.”
Walekhwa et al. (2026) “2. Methods”: “Movement is independent each day (no memory); only exposed and infectious individuals move, and the probability of moving is the same for both compartments.”
Walekhwa et al. (2026) “4. Discussion”: “The DTM data cover only a 10-day window and eight border crossing points; movements through unofficial crossings or after the outbreak escalated may not be captured, a limitation common to mobility-based epidemiological studies.”
Walekhwa et al. (2026) “2. Methods”: “The latent period was set to 7.5 days and the infectious period to 8.5 days, giving daily progression probabilities σ = 1/7.5 and γ = 1/8.5.”
Walekhwa et al. (2026) “2. Methods”: “The case fatality ratio (2/20 = 0.10) and HCW attack rate (3/20 = 0.15) remain constant.”
Walekhwa et al. (2026) “2. Methods”: “The DRC case fatality ratio was set to 64/381 = 0.168, based on reported outbreak data.”
Walekhwa et al. (2026) “2. Methods”: “The detection delay of 3 days applies uniformly to all infected individuals, and quarantine after detection is perfect.”
Walekhwa et al. (2026) “2. Methods”: “Reported incidence was the number of new cases on the previous day multiplied by the detection probability pdetect = 1.0 (assuming all symptomatic cases are detected).”
Walekhwa et al. (2026) “2. Methods”: “The DRC epidemic curve is independent of Uganda’s interventions and drives importations solely through the movement matrix.”
Walekhwa et al. (2026) “2. Methods”: “DRC response parameters were set to represent a moderately delayed response: detection delay 7 days (based on the 2018–2020 DRC outbreak), notification delay 3 days, response delay 5 days, contact tracing coverage 30%, detection probability 0.7, and no behavioural response (k = 1).”
Walekhwa et al. (2026) “2. Methods”: “Compliance with NPIs is constant over the 90 days and homogeneous across districts.”
Walekhwa et al. (2026) “2. Methods”: “No importations from countries other than DRC are considered.”
Walekhwa et al. (2026) “2. Methods”: “At each daily time step, the algorithm: computed the time-dependent mobility decay factor based on cumulative Ugandan cases; moved exposed and infectious individuals according to Mₜ using binomial draws; calculated the force of infection for each node, incorporating the behavioural response and the NPI multipliers; drew new exposures (binomial), new infections (negative binomial for superspreading, with dispersion parameter kdisp = 0.3), natural recoveries, and deaths (CFR = 2/20 = 0.10 for Uganda, 64/381 = 0.168 for DRC); applied dynamic contact tracing (coverage based on cumulative cases); and updated all compartments.”
Walekhwa et al. (2026) “4. Discussion”: “The homogeneous mixing assumption within districts likely overestimates transmission in low-density areas and underestimates it in high-density slums.”
Walekhwa et al. (2026) “4. Discussion”: “The Sobol confidence intervals for some parameters remained wide because the small outbreak size (median 22 cases) produces low output variance, making precise quantitative ranking unstable, hence our qualitative interpretation.”
Walekhwa et al. (2026) “4. Discussion”: “Hospital and funeral transmission are not explicitly modelled, a limitation given that Legrand et al. (2007) identified nosocomial transmission and unsafe burials as major amplifiers in Ebola outbreaks.”
Walekhwa et al. (2026) “4. Discussion”: “Importations from neighbouring countries other than DRC were not considered, though the 79.9% importation risk estimated by Chalma et al. (2026) focused specifically on DRC-origin introductions.”
Walekhwa et al. (2026) “2. Methods”: “First, the Ministry of Health EVD situation report as of June 5, 2026, provided the initial outbreak conditions. The report confirmed 15 cumulative cases (plus 1 probable), 2 deaths, 5 recoveries, and 720 cumulative contacts listed (455 active under follow-up). All initial cases were located in Kampala and were under institutional quarantine.”
Walekhwa et al. (2026) “2. Methods”: “We recalibrated the DRC model using actual reported data as of May 25, 2026: 381 confirmed cases, 2,987 exposed contacts, and 64 deaths. Nord-Kivu was initialised with 4,000 exposed and 400 infectious individuals, and Ituri with 500 exposed and 50 infectious, to reproduce these numbers.”
Walekhwa et al. (2026) “2. Methods”: “Second, the IOM DTM Flow Monitoring report covering 15–24 May 2026 summarised cross-border movements from DRC into Uganda and internal movements among Ugandan districts. From the report we extracted the total observed individuals (11,245) and the percentage distribution across eight Flow Monitoring Points (FMPs): Ntoroko Main (28%), Mpondwe (18%), Busunga (18%), Bunagana (12%), Cyanika (8%), Goli (8%), Vurra (3%), and Busanza (3%).”
Walekhwa et al. (2026) “2. Methods”: “Third, the official 2024 Uganda Population and Housing Census final report (UBOS, December 2024) gave the de facto population for each of the 135 districts. The total national population was 45,905,417.”
Walekhwa et al. (2026) “Research in Context”: “Previous outbreaks in Uganda (2007–08; 131 confirmed cases, 42 deaths) and DR Congo (2012; 38 confirmed cases, 13 deaths) suggested lower transmissibility and case-fatality ratio than Zaire ebolavirus, with reproduction number estimates ranging from 1.2 to 2.6.”
Walekhwa et al. (2026) “Research in Context”: “Concurrently, Bangelesa and colleagues conducted a population mobility mapping exercise in Ituri Province using monthly data from Flowminder (March 2025–March 2026) and computed a normalised mobility intensity index (MII) for all 340 health zones. Their analysis revealed that Ituri Province had the second highest average MII nationally (25.3), behind only Kinshasa (26.6), and 2.4 times the national median (10.7). Critically, the three outbreak epicentre health zones, Rwampara (MII 68.6, rank 2), Bunia (MII 62.6, rank 3), and Mongbwalu (MII 49.9, rank 11), all exceeded the 95th national percentile (41.4), underscoring the exceptional connectivity of the affected zones.”
Okingo, Iroungou, & Valdano (2026) “Abstract”: “During the ongoing Bundibugyo ebolavirus disease outbreak in the Democratic Republic of the Congo, we quantify introduction risk and sustained-transmission potential across the country. This identifies priority zones far from currently affected areas, where rapid amplification could follow introduction and response efforts should be focused.”
Okingo, Iroungou, & Valdano (2026) “Body”: “We used the method developed in Ref. 2 to estimate, for each DRC health zone (HZ), the potential for an introduced case to generate sustained transmission (hereafter, sustained-transmission potential). We used available population and mobility data to parameterize spatial transmission, testing a broad range of assumptions on disease transmissibility and on how local and between-community contact patterns can be inferred from these data. We ranked HZs by sustained-transmission potential and compared them with introduction-risk ranks estimated from mobility data.”
Okingo, Iroungou, & Valdano (2026) “Body”: “Crossing the two rankings identified eight HZs that combined high introduction risk and high sustained-transmission potential (Fig. 1E, F): Binza Ozone and Binza Meteo in Kinshasa; Karisimbi in Nord-Kivu; Kadutu and Ibanda in Sud-Kivu; and Makiso-Kisangani, Kabondo, and Mangobo in Tshopo.”
Okingo, Iroungou, & Valdano (2026) “Body”: “Introduction risk was highest in HZs close to the reported foci, specifically in Ituri, Nord-Kivu, and Haut-Uele, consistent with expected mobility patterns (Fig. 1A,B). Non-negligible risk of introduction also appeared in distant urban centers, including the Kinshasa area.”
Okingo, Iroungou, & Valdano (2026) “Body”: “By contrast, high sustained-transmission potential was distributed across DRC, including Kinshasa, Kasaï-Oriental, Kongo-Central, Tshopo, Nord-Kivu, Haut-Katanga, Sud-Kivu, Kasaï, and Kasaï-Central (Fig. 1C,D). Notably, several are far from the current outbreak.”
Okingo, Iroungou, & Valdano (2026) “Body”: “We used the method developed in Ref. 2 to estimate, for each DRC health zone (HZ), the potential for an introduced case to generate sustained transmission (hereafter, sustained-transmission potential).”
Okingo, Iroungou, & Valdano (2026) “Body”: “We used available population and mobility data to parameterize spatial transmission, testing a broad range of assumptions on disease transmissibility and on how local and between-community contact patterns can be inferred from these data.”
Okingo, Iroungou, & Valdano (2026) “Figure 1: Introduction risk and sustained-transmission potential across health zones.”: “Population data are from worldpop.org. Mobility data are from flowminder.org.”
Okingo, Iroungou, & Valdano (2026) “Body”: “We ranked HZs by sustained-transmission potential and compared them with introduction-risk ranks estimated from mobility data.”
Okingo, Iroungou, & Valdano (2026) “Body”: “Unlike risk estimates, risk rankings were robust across scenarios and assumptions and can therefore inform action despite limited knowledge of transmissibility and contact patterns.”
Okingo, Iroungou, & Valdano (2026) “Body”: “This requires estimating introduction risk and, more importantly, the potential for sustained onward transmission, despite limited data on human mobility, contact patterns, disease transmissibility, tracing and isolation capacity.”
Okingo, Iroungou, & Valdano (2026) “Body”: “Insecurity, high population mobility, limited healthcare capacity, and the absence of a vaccine pose challenges to response.”
Okingo, Iroungou, & Valdano (2026) “Body”: “This is relevant because several high-amplification areas are in Kinshasa, Kasaï, and Tshopo, where preparedness may be more feasible than in parts of eastern DRC despite heterogeneous healthcare access, accessibility constraints, and low-to-moderate insecurity outside Kinshasa.”
Okingo, Iroungou, & Valdano (2026) “Figure 1: Introduction risk and sustained-transmission potential across health zones.”: “Methodology, additional data sources, additional results and tabled values are available in the Appendix.”
Okingo, Iroungou, & Valdano (2026) “Body”: “An outbreak of Bundibugyo virus disease is ongoing in Ituri province, Democratic Republic of the Congo (DRC).”
Okingo, Iroungou, & Valdano (2026) “Body”: “As of June 4, confirmed cases in Nord-Kivu and Sud-Kivu indicate that the spread has gone beyond the initial focus.”
Kinoshita, Suzuki, & Yoneoka (2026) “Abstract”: “During the 2026 Bundibugyo virus disease outbreak in the Democratic Republic of the Congo and Uganda, we projected potential airline-mediated importation risk using contemporary airline network and an externally calibrated Ebola importation hazard.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Airport-level arrival probabilities, interpreted as the probability of at least one airline-mediated importation until the end of June, 2026 ( t = 44), varied substantially across the global airline network (Figure 2). The probability ranged from 0.247 to 0.937 (mean of 0.431).”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Higher arrival probabilities were concentrated among airports with shorter effective distances from FIH and stronger connectivity through major transit hubs: for example, 0.889 in Brussels Airport, 0.888 in Paris Charles de Gaulle Airport, and 0.871 in Johannesburg O.R. Tambo International Airport (Supplementary Table 1).”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “The highest 30-day country-level arrival probabilities were observed in major international hub countries including Belgium, France, South Africa, Kenya, and the United Arab Emirates, with the top-ranked countries all exceeding 0.77, whose probaility ranged from 0.38 to 0.98 in the sensitivity analysis.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “The sensitivity analysis shows that the probability had a similar geographical tendency, even if the starting airport is assumed to be EBB: the mean (standard deviation) ranged from 0.170 (0.049) to 0.616 (0.099) (Supplementary Figures 1-5 and Supplementary Table 2).”
Kinoshita, Suzuki, & Yoneoka (2026) “Abstract”: “We projected the potential airline-mediated importation risk during the 2026 DRC-Uganda outbreak using a hazard-based model informed by contemporary airline transportation networks and a hazard parameter calibrated from the 2013-2016 West African Ebola virus disease (EVD) epidemic, one of the few EBOD outbreaks with documented long-distance airline-mediated international exportations.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “To model the global spread on airline network, we first constructed a directed, weighted air-traffic network using airport-level origin-destination passenger-flow data from OAG for May 2024. OAG is a global travel data provider listed in the IATA Strategic Partners Directory and provides aviation schedules, status data, and analytics products for the air-travel ecosystem. The network includes 11,264 airports (nodes), 569,741 routes (edges) and 329,326,078 passengers.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Given a single airport-level adjacency matrix A , where A ij denotes the number of passenger volume travelling from airport i to j during May 2024, the shortest-path effective distance from Kinshasa/N’djili International Airport (IATA code: FIH) to airport j was defined by , where Γ ij indicates the set of all directed paths from airport i to j and γ is one path. Shortest paths were calculated on the directed network using Dijkstra’s algorithm.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Then, to estimate the arrival probability using the effective distance, we modeled the arrival hazard at airport j as λ j = θ/ D j , where θ = 0.19 is used as the primary value based on a previous EBOD importation hazard model. The arrival probability that infection reaches airport j within t days is calculated by p j ( t ) = 1 - exp(- tλ j ).”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Further, the country-level arrival risk was summarized as the maximum airport-level probability within each country: , where A c denotes the set of airports located in country c .”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “As the sensitivity analysis, we checked θ = {0.06, 0.32} based on the 95% confidence interval of.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “In the sensitivity analysis, δ can be also estimated from, where r is the epidemic growth rate ( r = {0.034, 0.05, 0.1} estimated as of May 17, 2026, γ e is the Euler-Mascheroni constant ( γ e ≈ 0.58), and α FIH is the outbound passenger flow from FIH divided by the assumed FIH catchment population α FIH ≈ 0.0001.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Here, we assume that the relationship between effective distance and EVD importation observed in 2013-2016 was transferable to the current BVD outbreak. The estimated effective distance distribution was very similar to that in the previous study, supporting the use of same θ value on a comparable hazard scale.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “In the main analyses, disease-specific values of δ was set to 1, which assumes that the each additional travel step contributes one unit of distance, and thus corresponds to the Brockmann-Helbing scale. This scale has been empirically shown to effectively predict the global spread patterns of infectious diseases.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “In the sensitivity analysis, δ can be also estimated from, where r is the epidemic growth rate ( r = {0.034, 0.05, 0.1} estimated as of May 17, 2026, γ e is the Euler-Mascheroni constant ( γ e ≈ 0.58), and α FIH is the outbound passenger flow from FIH divided by the assumed FIH catchment population α FIH ≈ 0.0001. While this δ formulation allows us to incorporate information about the current epidemic situation by adding more parameters, it also increases uncertainty.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Sensitivity analyses using the lower and upper bounds of the historical parameter changed absolute arrival probabilities but broadly preserved the overall pattern of higher-probability airports. This is expected because effective distance determines the spatial pattern, whereas the hazard parameter mainly scales the probabilies.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Our estimates also relied on 2024 airline network data and therefore may not capture subsequent changes in routes, passenger volumes, airspace restrictions, or travel advisories, including those affecting routes through Russia and the Middle East.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “The projections also did not explicitly account for post-PHEIC interventions, enhanced screening or behavioural changes.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “More importantly, our analysis focused on global air travel originationg from FIH, with EBB considered in sensitivity analysis, and did not explicitly account for land-based spread within the DRC or cross-border movements to neighboring countries.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Estimated arrival probability should be interpreted as importation risk rather than the risk of local transmission after arrival. Importation does not necessarily lead to onward spread because EBOD requires direct contact with infectious body fluids or contaminated materials, and timely detection, isolation, contact tracing and infection prevention and control can reduce transmission.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Because no airline-mediated importation had been reported so far as of 28 May 2026, we used a hazard parameter estimated using the 2013-2016 West African EVD epidemic. Here, we assume that the relationship between effective distance and EVD importation observed in 2013-2016 was transferable to the current BVD outbreak.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Our estimates also relied on 2024 airline network data and therefore may not capture subsequent changes in routes, passenger volumes, airspace restrictions, or travel advisories, including those affecting routes through Russia and the Middle East. The projections also did not explicitly account for post-PHEIC interventions, enhanced screening or behavioural changes.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Estimated arrival probability should be interpreted as importation risk rather than the risk of local transmission after arrival.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Thus, countries with high-probability airport gateways should be interpreted as priorities for awareness and preparedness, rather than as locations where local outbreaks are expected.”
Kinoshita, Suzuki, & Yoneoka (2026) “Abstract”: “As of 4 June 2026, the DRC had reported 363 confirmed cases, including 62 deaths. Uganda had reported 15 confirmed cases, including one death.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Because no airline-mediated importation had been reported so far as of 28 May 2026, we used a hazard parameter estimated using the 2013-2016 West African EVD epidemic.”
Kinoshita, Suzuki, & Yoneoka (2026) “Airline-flow-based network and effective distance for hazard estimation”: “Then, to estimate the arrival probability using the effective distance, we modeled the arrival hazard at airport j as λ j = θ/ D j , where θ = 0.19 is used as the primary value based on a previous EBOD importation hazard model.”
Richard et al. (2026) “Abstract”: “In response to reports of high numbers of suspected cases and deaths in the affected countries, CDC assessed the risk posed by the BVD outbreak to the U.S. population during the next 3 months. This analysis used a standardized risk assessment approach that included epidemiologic data from the ongoing outbreak and historical data from previous Ebola outbreaks; the overall risk was determined by taking into account independent assessments of the likelihood of infection and the impact of infection.”
Richard et al. (2026) “Methods”: “Overall risk to the U.S. population was determined by independently assessing two factors: (1) the likelihood of infection and (2) the impact of infection.”
Richard et al. (2026) “Abstract”: “The assessment found that the overall risk to the U.S. population posed by the current BVD outbreak during the next 3 months is low, based on the extremely low likelihood of transmission, despite the high impact that potential infection could have and the resources that would be required to respond to the outbreak.”
Richard et al. (2026) “Results”: “This overall risk was determined based on a combination of extremely low likelihood of infection, but high impact of infection for the U.S. population, were it to occur. The likelihood of Bundibugyo virus infection for the U.S. population was assessed as extremely low.”
Richard et al. (2026) “Results”: “These modeling results suggested that the relative risk of importation to the United States compared with other locations was 1.3%.”
Richard et al. (2026) “Results”: “The impact of infection, based on the standardized framework, was assessed as high, primarily based on the severity of the illness, lack of available medications and vaccines, and resources required to respond to the current outbreak. In the two previously identified outbreaks of BVD in Uganda in 2007 and DRC in 2012, case-fatality rates ranged from 25% to 50%.”
Richard et al. (2026) “Methods”: “CDC subject matter experts in risk assessment methodology, infectious disease modeling, global health, and Ebola disease and viral hemorrhagic fevers collaborated to develop this assessment. These experts used a standardized risk assessment approach that has been applied to previous viral hemorrhagic fever outbreaks. They considered available evidence including epidemiologic data from the ongoing BVD outbreak and historical data on Bundibugyo virus and other Ebola disease outbreaks.”
Richard et al. (2026) “Methods”: “Overall risk to the U.S. population was determined by independently assessing two factors: (1) the likelihood of infection and (2) the impact of infection. † The likelihood of infection refers to the probability that members of the U.S. population would acquire Bundibugyo virus infection during the next 3 months; this, in turn, depends on the likelihood of exposure, infectiousness of the virus, and susceptibility of the population. The impact of infection refers to the consequences of infection in this population. Factors include the severity of disease, level of population immunity to severe disease, availability of medications and vaccines, and necessary public health response resources.”
Richard et al. (2026) “Methods”: “Experts then assigned a degree of confidence to the assessment, taking into account evidence quality, extent, and corroboration of information.”
Richard et al. (2026) “Results”: “Despite the large number of cases identified at the time the outbreak was reported, the current likelihood for potential spread of BVD from DRC to the United States, via travelers from DRC who might be infected, is considered very low based on modeling results that consider population movement. These modeling results suggested that the relative risk of importation to the United States compared with other locations was 1.3%.”
Richard et al. (2026) “Results”: “Despite the large number of cases identified at the time the outbreak was reported, the current likelihood for potential spread of BVD from DRC to the United States, via travelers from DRC who might be infected, is considered very low based on modeling results that consider population movement.”
Richard et al. (2026) “Results”: “If BVD were to be introduced into the United States, based on historical observation and the known epidemiology of BVD, secondary transmission would likely be minimal.”
Richard et al. (2026) “Results”: “Although BVD symptoms can appear suddenly and might be nonspecific, these public health measures are highly effective against Ebola disease, in part because the average interval between cases is long (10–16 days), and because persons are not known to be infectious before the onset of symptoms.”
Richard et al. (2026) “Methods”: “Risk was assessed only for the general U.S. population; however, subpopulations that might have different assessments of likelihood are noted, based on varying risk factors.”
Richard et al. (2026) “Results”: “Although the likelihood of infection for the general U.S. population is low, the likelihood of infection might be higher among U.S. health care workers practicing in or who have recently returned from affected regions in DRC and Uganda based on possible exposure risks.”
Richard et al. (2026) “Results”: “In the two previously identified outbreaks of BVD in Uganda in 2007 and DRC in 2012, case-fatality rates ranged from 25% to 50%. However, many of the deaths in these outbreaks occurred in locations where health resources are limited; clinical outcomes might improve with the specialized care available in the United States.”
Richard et al. (2026) “Results”: “However, this assessment also recognizes uncertainties about the epidemiology of BVD, the scope and geographic spread of the outbreak, and the potential timelines for implementation of interventions.”
Richard et al. (2026) “Discussion”: “First, given that only two previous BVD outbreaks have occurred, less is known about Bundibugyo virus than other types of orthoebolaviruses that cause human illness (e.g., O. zairense, which was responsible for the 2014–2016 Ebola virus disease outbreak in West Africa).”
Richard et al. (2026) “Discussion”: “Second, limited confirmatory diagnostic testing and challenges in contact tracing that likely resulted in undetected transmission mean that the full scope of the current outbreak is unclear, making it difficult to assess the potential geographic spread of the outbreak and the subsequent potential for spread to the United States.”
Richard et al. (2026) “Discussion”: “Finally, although DRC and neighboring countries have extensive experience responding to outbreaks of viral hemorrhagic fevers, several features of this outbreak pose challenges to assessing its future trajectory, including that the outbreak is occurring in a region with ongoing conflict and unpredictable infrastructure, and the initial large size of the outbreak combined with limited confirmatory diagnostic testing might lead to challenges in infection prevention and control efforts.”
Richard et al. (2026) “Abstract”: “Limitations to this assessment included uncertainties around the epidemiology of BVD as well as the current and future scope and geographic spread of the outbreak.”
Richard et al. (2026) “Introduction”: “As of June 2, 2026, a total of 378 confirmed BVD cases and 63 deaths have been reported in the Democratic Republic of the Congo (DRC) and Uganda.”
Richard et al. (2026) “Methods”: “They considered available evidence including epidemiologic data from the ongoing BVD outbreak and historical data on Bundibugyo virus and other Ebola disease outbreaks.”
Richard et al. (2026) “Results”: “In the two previously identified outbreaks of BVD in Uganda in 2007 and DRC in 2012, case-fatality rates ranged from 25% to 50%.”
Richard et al. (2026) “Results”: “Only 11 persons infected with Ebola disease have ever been treated in the United States; all were associated with the 2014–2016 Ebola virus disease outbreak in West Africa. Despite two instances of secondary transmission to U.S. health care workers during that outbreak, no community spread occurred in the United States.”
Fanelli et al. (2026b) “Abstract”: “Using International Air Transport Association origin-destination passenger flows, we assessed relative exposure to Ebola virus disease importation into Europe under six outbreak expansion scenarios reflecting plausible pathways of geographical spread, including cross-border transmission and amplification in highly connected regional capitals.”
Fanelli et al. (2026b) “Abstract”: “Across all scenarios, France, Italy, and the United Kingdom remained among the most exposed countries.”
Fanelli et al. (2026b) “Text”: “Potential spread across the Ugandan border produced no change in either the relative exposure of European countries (Fig. 1b) or their overall importation pressure (Fig. 1c), compared with the currently reported localized transmission in eastern DRC, with Italy, France, Belgium, and the UK being the most exposed.”
Fanelli et al. (2026b) “Text”: “Expansion across the border to South Sudan produced a first structural increase in importation pressure through the connectivity associated to Juba (5-fold increase for Northern Europe and 6-fold increase for Eastern Europe relative to localized transmission in DRC), while still leaving UK, France, and Italy among the highest-risk countries.”
Fanelli et al. (2026b) “Text”: “Kampala and Kigali amplification increased exposure in Northern Europe, with Kampala producing a >120-fold increase in importation pressure relative to localized transmission in DRC. Kinshasa amplification instead primarily reinforced exposure in Western Europe (~80-fold increase).”
Fanelli et al. (2026b) “Appendix”: “Results do not show notable differences with those reported in the main text (Figure S2, S3), with the exception of the Kampala amplification scenario, in which the increase in importation pressure for Northern Europe rises to approximately 190-fold when using monthly averages of 2024 travel data.”
Fanelli et al. (2026b) “Appendix”: “We use origin-destination (O&D) passenger flows derived from the 2024 International Air Transport Association (IATA) database to reconstruct intercontinental and regional travel patterns at the airport level. The IATA O&D data capture complete passenger itineraries, including traffic travelling via connecting flights rather than only direct flight segments.”
Fanelli et al. (2026b) “Appendix”: “The relative importation risk to country c was estimated as the proportion of total outgoing passenger flow from the selected seed airports directed to the country, for each scenario: where denotes the origin-destination passenger flow from airport , among the set of origin airports included in scenario , and airport in the set of airports of the destination destination country . The relative risk of importation for each European country was normalized to the total passenger flow from the source airports to Europe.”
Fanelli et al. (2026b) “Appendix”: “Risks were then stratified by subregion.”
Fanelli et al. (2026b) “Appendix”: “To account for potential seasonal effects in travel patterns, we conducted the analysis using average monthly data from the full 2024. Results do not show notable differences with those reported in the main text (Figure S2, S3), with the exception of the Kampala amplification scenario, in which the increase in importation pressure for Northern Europe rises to approximately 190-fold when using monthly averages of 2024 travel data.”
Fanelli et al. (2026b) “Text”: “We considered six outbreak expansion scenarios designed to reflect plausible pathways of geographical spread from the currently affected area through porous borders (Fig. 1a, Appendix).”
Fanelli et al. (2026b) “Appendix”: “All analyses presented in this report are based on the cumulative passenger traffic reported for May, June, and July 2024. Data from 2024 showed moderate seasonal variability in passenger traffic to Europe. Relative to the annual traffic to Europe, mean passenger volumes during MayJuly ranged from 3% below to 16% above the monthly 2024 average across scenarios.”
Fanelli et al. (2026b) “Text”: “Scenarios 4-6 explored hypothetical amplification assuming community transmission in major urban hubs-Kampala, Kigali, and Kinshasa.”
Fanelli et al. (2026b) “Text”: “Patterns of Ebola virus importation risk to Europe may rapidly shift under uncertainty surrounding the geographical extent and evolution of the outbreak, particularly if transmission expands into major urban hubs with strong international connectivity near the affected area.”
Fanelli et al. (2026b) “Text”: “As of 29 May 2026, the Bundibugyo Ebola outbreak, a Public Health Emergency of International Concern, involved 125 confirmed cases (17 deaths), and 906 suspected cases (223 deaths) across Ituri, North Kivu, and South Kivu provinces in Eastern DRC, and 9 confirmed cases (1 death) in Uganda.”
Fanelli et al. (2026b) “Appendix”: “All analyses presented in this report are based on the cumulative passenger traffic reported for May, June, and July 2024.”
Fanelli et al. (2026b) “Appendix”: “Relative to the annual traffic to Europe, mean passenger volumes during MayJuly ranged from 3% below to 16% above the monthly 2024 average across scenarios.”
van Zandvoort et al. (2026) “Ebola disease cases outside Africa”: “We conducted internet searches for all laboratory-confirmed Ebola disease cases presenting outside Africa, performing both manual and artificial intelligence (AI)-assisted internet searches to identify scientific articles, public health bulletins and news reports without any time limit.”
van Zandvoort et al. (2026) “Summary”: “Following the Bundibugyo virus disease outbreak reported in the Democratic Republic of the Congo in May 2026, we reviewed all known Ebola disease cases outside Africa and found that intercontinental transmission risk remains low.”
van Zandvoort et al. (2026) “Low overall risk of exportation”: “This gives a crude risk estimate of 0.81 cases outside Africa, including medically evacuated, latent and secondary cases, per 1,000 Ebola disease cases in a source outbreak (Table 2). Focusing on latent cases and their secondary cases only, there have been 0.17 cases outside Africa per 1,000 Ebola disease cases in the source outbreak.”
van Zandvoort et al. (2026) “Low overall risk of exportation”: “Of note, this represents the empirically observed risk of importation (and onward transmission) across all countries outside Africa; per-country risks are smaller. For example, focusing only on the UK, there has been one latent Ebola disease case since 2000, giving a risk estimate of 0.03 latent UK cases for every 1,000 Ebola disease cases in a source outbreak.”
van Zandvoort et al. (2026) “Decrease in exportation risk over the 2014–16 epidemic”: “Over the course of the epidemic, the case exportation risk per reported source outbreak case decreased by 4.6% per week (95% CI: 1.7–7.4%; p = 0.0097). More generally, the case exportation risk was substantially lower after the epidemic peak (0.46; 95% CI: 0.17–0.73 exported cases per 1,000 source cases from 27 October 2014 onwards) than it was before the peak (1.7; 95% CI: 0.95–2.7 exported cases per 1,000 source cases).”
van Zandvoort et al. (2026) “Summary”: “We identified and analysed all known Ebola disease cases outside Africa to contextualise intercontinental spread and assess the risk of undetected Orthoebolavirus transmission outside Africa. We conducted internet searches for all laboratory-confirmed Ebola disease cases presenting outside Africa, performing both manual and artificial intelligence (AI)-assisted internet searches to identify scientific articles, public health bulletins and news reports without any time limit.”
van Zandvoort et al. (2026) “Low overall risk of exportation”: “As a crude measure of risk, we calculated for Ebola disease outbreaks since the year 2000 the number of cases occurring outside Africa per 1,000 reported cases in the originating epidemic. This gives a crude risk estimate of 0.81 cases outside Africa, including medically evacuated, latent and secondary cases, per 1,000 Ebola disease cases in a source outbreak (Table 2). Focusing on latent cases and their secondary cases only, there have been 0.17 cases outside Africa per 1,000 Ebola disease cases in the source outbreak.”
van Zandvoort et al. (2026) “Decrease in exportation risk over the 2014–16 epidemic”: “For cases exported from the 2014–16 epidemic in Western Africa, we carried out a time-varying risk analysis using Poisson regression of the number of exported cases for a given epidemiological week and country (across Guinea, Liberia and Sierra Leone, including weeks with no exported cases, from 6 January 2014 to 20 December 2015) against (i) the number of cases reported for that epidemiological week and country and (ii) the number of weeks since 6 January 2014 as a linear predictor of time-varying risk.”
van Zandvoort et al. (2026) “Decrease in exportation risk over the 2014–16 epidemic”: “The number of exported cases (both medically evacuated and latent) closely scaled with the number of cases in the source country in that week (Figure 2), with no significant deviation from linear scaling (estimated scaling: 0.98; 95% CI (confidence interval): 0.60–1.36; p = 0.86).”
van Zandvoort et al. (2026) “Discussion”: “A key distinction in our analysis is between medically evacuated and latent Ebola disease cases. While medically evacuated cases represent known risks that can be mitigated with strict biosecurity measures, latent cases arriving via commercial flights need to be diagnosed before they can be isolated.”
van Zandvoort et al. (2026) “Discussion”: “Agreement among search methods and with a clinical review of exported cases from 2014 to 2016 support that our list is likely complete. Nonetheless, potential sources of under-ascertainment include that public health bulletins published not in English were underrepresented despite targeted native language searches, and web-based search tools may have returned geographically biased results.”
van Zandvoort et al. (2026) “Discussion”: “Nonetheless, potential sources of under-ascertainment include that public health bulletins published not in English were underrepresented despite targeted native language searches, and web-based search tools may have returned geographically biased results.”
van Zandvoort et al. (2026) “Decrease in exportation risk over the 2014–16 epidemic”: “As most exported primary cases during this epidemic (20 of 24) were medical evacuations, this is likely to be most consistent with improvement in infection prevention and control measures coinciding with the stepping-up of response efforts in late 2014, as further evidenced by decreasing transmission after the peak of the epidemic.”
van Zandvoort et al. (2026) “Low overall risk of exportation”: “Of note, this represents the empirically observed risk of importation (and onward transmission) across all countries outside Africa; per-country risks are smaller.”
van Zandvoort et al. (2026) “Discussion”: “Notably, the four latent cases we identified occurred among 300,000 travellers screened by the US Centers for Disease Control and Prevention (CDC)-supported exit screening programmes in Guinea, Liberia and Sierra Leone, and all were asymptomatic (and hence undetectable) at the point of both exit screening and entry screening. Screening protocols included clear guidance on procedures for self-monitoring of symptoms, which ultimately led to rapid confirmation and isolation among the three latent cases in medical workers.”
van Zandvoort et al. (2026) “Ebola disease cases outside Africa”: “We identified 28 confirmed Ebola disease cases outside Africa: 25 primary imported cases and three secondary cases infected by another patient in the United States (US) or Europe (Table 1, Figure 1). Of these, 27 occurred during the 2014–16 Ebola virus epidemic in Western Africa and one has occurred so far during the ongoing 2026 Bundibugyo virus epidemic.”
van Zandvoort et al. (2026) “Ebola disease cases outside Africa”: “In total, we included 27 scientific articles, 9 reports in public health bulletins, 82 news articles and 9 other sites in gathering data.”
van Zandvoort et al. (2026) “Decrease in exportation risk over the 2014–16 epidemic”: “Weekly count of new confirmed, probable and suspected cases, by week and country for Guinea, Liberia and Sierra Leone (total 28,592).”
van Zandvoort et al. (2026) “Discussion”: “Notably, the four latent cases we identified occurred among 300,000 travellers screened by the US Centers for Disease Control and Prevention (CDC)-supported exit screening programmes in Guinea, Liberia and Sierra Leone, and all were asymptomatic (and hence undetectable) at the point of both exit screening and entry screening.”
van Zandvoort et al. (2026) “Ebola disease cases outside Africa”: “We checked our findings against existing lists of Ebola disease cases.”